{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T18:13:54Z","timestamp":1789150434761,"version":"build-2803163510"},"reference-count":451,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000},"content-version":"am","delay-in-days":222,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000070","name":"National Institute of Biomedical Imaging and Bioengineering","doi-asserted-by":"publisher","award":["R56EB029259"],"award-info":[{"award-number":["R56EB029259"]}],"id":[{"id":"10.13039\/100000070","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Coordination Chemistry Reviews"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.ccr.2025.216764","type":"journal-article","created":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T18:22:16Z","timestamp":1749666136000},"page":"216764","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Coordination chemistry of emerging Meitner-Auger electron-emitting radiometals for targeted radionuclide therapy"],"prefix":"10.1016","volume":"542","author":[{"given":"Grant J.","family":"Stec","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin J.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ccr.2025.216764_bb0005","first-page":"544","article-title":"Recent advances in targeted radionuclide therapy for cancer treatment","volume":"10","author":"Goel","year":"2023","journal-title":"Chem. Biol. Let."},{"key":"10.1016\/j.ccr.2025.216764_bb0010","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41573-020-0073-9","article-title":"Radiopharmaceutical therapy in cancer: clinical advances and challenges","volume":"19","author":"Sgouros","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ccr.2025.216764_bb0015","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.ijrobp.2020.08.035","article-title":"Current status of radiopharmaceutical therapy","volume":"109","author":"St","year":"2021","journal-title":"Int J. Radiat. Oncol. *Biol. *Physics"},{"key":"10.1016\/j.ccr.2025.216764_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-024-02041-6","article-title":"Radiopharmaceuticals and their applications in medicine","volume":"10","author":"Zhang","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.ccr.2025.216764_bb0025","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.3390\/pharmaceutics15061733","article-title":"Clinical advances and perspectives in targeted radionuclide therapy","volume":"15","author":"Lepareur","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ccr.2025.216764_bb0030","doi-asserted-by":"crossref","first-page":"T121","DOI":"10.1530\/ERC-21-0037","article-title":"Radioiodine treatment: an historical and future perspective","volume":"28","author":"Borges de Souza","year":"2021","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.ccr.2025.216764_bb0035","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1001\/jama.1946.02870190010003","article-title":"The treatment of hyperthyroidism with radioactive iodine","volume":"131","author":"Chapman","year":"1946","journal-title":"JAMA"},{"key":"10.1016\/j.ccr.2025.216764_bb0040","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1001\/jama.1946.02870190005002","article-title":"Radioactive iodine in the study of thyroid physiology. VII. The use of radioactive iodine therapy in hyperthyroidism","volume":"131","author":"Hertz","year":"1946","journal-title":"JAMA"},{"key":"10.1016\/j.ccr.2025.216764_bb0045","doi-asserted-by":"crossref","first-page":"4720","DOI":"10.1039\/c3cc41554f","article-title":"Tumour targeting with radiometals for diagnosis and therapy","volume":"49","author":"Ramogida","year":"2013","journal-title":"Chem. Commun."},{"key":"10.1016\/j.ccr.2025.216764_bb0050","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1039\/C3CS60304K","article-title":"Matching chelators to radiometals for radiopharmaceuticals","volume":"43","author":"Price","year":"2014","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.ccr.2025.216764_bb0055","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1021\/acs.chemrev.8b00294","article-title":"Radioactive main group and rare earth metals for imaging and therapy","volume":"119","author":"Kostelnik","year":"2019","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ccr.2025.216764_bb0060","doi-asserted-by":"crossref","first-page":"1169650","DOI":"10.3389\/fnume.2023.1169650","article-title":"A brief overview of targeted radionuclide therapy trials in 2022","volume":"3","author":"Healy","year":"2023","journal-title":"Front. Nucl. Med."},{"key":"10.1016\/j.ccr.2025.216764_bb0065","first-page":"4S","article-title":"Radiobiologic principles in radionuclide therapy","volume":"46","author":"Kassis","year":"2005","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.ccr.2025.216764_bb0070","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1053\/j.semnuclmed.2008.05.002","article-title":"Therapeutic radionuclides: biophysical and radiobiologic principles","volume":"38","author":"Kassis","year":"2008","journal-title":"Semin. Nucl. Med."},{"key":"10.1016\/j.ccr.2025.216764_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.apradiso.2022.110569","article-title":"Targeted radionuclide therapy directed to the tumor phenotypes: a dosimetric approach using MC simulations","volume":"192","author":"Borbinha","year":"2023","journal-title":"Appl. Radiat. Isot."},{"key":"10.1016\/j.ccr.2025.216764_bb0080","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/rpd\/52.1-4.229","article-title":"Auger electron emitters as tools for elucidating the location of primary radiosensitive targets","volume":"52","author":"Narra","year":"1994","journal-title":"Radiat. Prot. Dosim."},{"key":"10.1016\/j.ccr.2025.216764_bb0085","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1093\/rpd\/ncq385","article-title":"Molecular and cellular radiobiological effects of Auger emitting radionuclides","volume":"143","author":"Kassis","year":"2011","journal-title":"Radiat. Prot. Dosim."},{"key":"10.1016\/j.ccr.2025.216764_bb0090","doi-asserted-by":"crossref","first-page":"996","DOI":"10.3389\/fphar.2018.00996","article-title":"Subcellular targeting of theranostic radionuclides","volume":"9","author":"Bavelaar","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ccr.2025.216764_bb0095","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1667\/RR14727.1","article-title":"The exploitation of low-energy electrons in cancer treatment","volume":"188","author":"Rezaee","year":"2017","journal-title":"Radiat. Res."},{"key":"10.1016\/j.ccr.2025.216764_bb0100","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s41181-019-0075-2","article-title":"Auger electrons for cancer therapy \u2013 a review","volume":"4","author":"Ku","year":"2019","journal-title":"EJNMMI Radiopharm. Chem."},{"key":"10.1016\/j.ccr.2025.216764_bb0105","series-title":"Radiopharmaceuticals for Therapy","first-page":"3","article-title":"Introduction: radiopharmaceuticals play an important role in both diagnostic and therapeutic nuclear medicine","author":"Knapp","year":"2016"},{"key":"10.1016\/j.ccr.2025.216764_bb0110","series-title":"Radiopharmaceuticals for Therapy","first-page":"25","article-title":"Therapeutic radionuclides decay with particle emission for therapeutic applications","author":"Knapp","year":"2016"},{"key":"10.1016\/j.ccr.2025.216764_bb0115","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.2967\/jnumed.122.265039","article-title":"Marshalling the potential of Auger electron radiopharmaceutical therapy","volume":"64","author":"Bolcaen","year":"2023","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.ccr.2025.216764_bb0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nucmedbio.2020.12.001","article-title":"Potent candidates for targeted Auger therapy: production and radiochemical considerations","volume":"94\u201395","author":"Filosofov","year":"2021","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.ccr.2025.216764_bb0125","doi-asserted-by":"crossref","DOI":"10.1186\/s41181-022-00173-0","article-title":"Cutting edge rare earth radiometals: prospects for cancer theranostics","volume":"7","author":"Sadler","year":"2022","journal-title":"EJNMMI Radiopharm. Chem."},{"key":"10.1016\/j.ccr.2025.216764_bb0130","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1021\/acs.chemrev.8b00281","article-title":"Radioactive transition metals for imaging and therapy","volume":"119","author":"Boros","year":"2019","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ccr.2025.216764_bb0135","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.nucmedbio.2021.02.001","article-title":"Status and future perspectives of Meitner-Auger and low energy electron-emitting radionuclides for targeted radionuclide therapy","volume":"94\u201395","author":"Radchenko","year":"2021","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.ccr.2025.216764_bb0140","series-title":"Monoclonal Antibody and Peptide-Targeted Radiotherapy of Cancer","first-page":"289","article-title":"Targeted Auger electron radiotherapy of malignancies","author":"Reilly","year":"2010"},{"key":"10.1016\/j.ccr.2025.216764_bb0145","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/BF01326962","article-title":"\u00dcber die Entstehung der \u03b2-Strahl-Spektren Radioaktiver Substanzen","volume":"9","author":"Meitner","year":"1922","journal-title":"Z. Phys."},{"key":"10.1016\/j.ccr.2025.216764_bb0150","first-page":"169","article-title":"Sur les rayons \u03b2 secondaires produits dans un gaz par des rayons X","volume":"177","author":"Auger","year":"1923","journal-title":"C. R. Acad. Sci."},{"key":"10.1016\/j.ccr.2025.216764_bb0155","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.nucmedbio.2021.03.002","article-title":"Auger: the future of precision medicine","volume":"96\u201397","author":"Pirovano","year":"2021","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.ccr.2025.216764_bb0160","series-title":"Atomic Inner-Shell Processes","first-page":"293","article-title":"7 - Auger and Coster\u2013Kronig transitions","author":"McGuire","year":"1975"},{"key":"10.1016\/j.ccr.2025.216764_bb0165","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0031-8914(35)90060-X","article-title":"New type of Auger effect and its influence on the X-ray spectrum","volume":"2","author":"Coster","year":"1935","journal-title":"Physica"},{"key":"10.1016\/j.ccr.2025.216764_bb0170","series-title":"Auger Electron Spectroscopy","year":"1988"},{"key":"10.1016\/j.ccr.2025.216764_bb0175","series-title":"Practical Surface Analysis: Auger and X-Ray Photoelectron Spectroscopy","year":"1990"},{"key":"10.1016\/j.ccr.2025.216764_bb0180","series-title":"Surface Analysis by Auger and X-Ray Photoelectron Spectroscopy","year":"2003"},{"key":"10.1016\/j.ccr.2025.216764_bb0185","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1667\/RR1359.1","article-title":"Cell membrane is a more sensitive target than cytoplasm to dense ionization produced by Auger electrons","volume":"170","author":"Pouget","year":"2008","journal-title":"Radiat. Res."},{"key":"10.1016\/j.ccr.2025.216764_bb0190","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.2967\/jnumed.109.066993","article-title":"Noninternalizing monoclonal antibodies are suitable candidates for 125I radioimmunotherapy of small-volume peritoneal carcinomatosis","volume":"50","author":"Santoro","year":"2009","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.ccr.2025.216764_bb0195","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1089\/ars.2015.6309","article-title":"Localized irradiation of cell membrane by Auger electrons is cytotoxic through oxidative stress-mediated nontargeted effects","volume":"25","author":"Paillas","year":"2016","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.ccr.2025.216764_bb0200","first-page":"2089","article-title":"Radionuclides linked to a CD74 antibody as therapeutic agents for B-cell lymphoma: comparison of Auger electron emitters with \u03b2-particle emitters","volume":"41","author":"Govindan","year":"2000","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.ccr.2025.216764_bb0205","first-page":"1505","article-title":"Therapy of disseminated B-cell lymphoma xenografts in severe combined immunodeficient mice with an anti-CD74 antibody conjugated with 111indium, 67gallium, or 90yttrium","volume":"7","author":"Ochakovskaya","year":"2001","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ccr.2025.216764_bb0210","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.addr.2015.12.003","article-title":"Radioimmunotherapy of cancer with high linear energy transfer (LET) radiation delivered by radionuclides emitting \u03b1-particles or Auger electrons","volume":"109","author":"Aghevlian","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ccr.2025.216764_bb0215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nucmedbio.2021.03.012","article-title":"Targeted Auger electron-emitter therapy: radiochemical approaches for thallium-201 radiopharmaceuticals","volume":"98\u201399","author":"Rigby","year":"2021","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.ccr.2025.216764_bb0220","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1002\/(SICI)1097-0142(19971215)80:12+<2656::AID-CNCR42>3.0.CO;2-8","article-title":"Can occult metastases be treated by radioimmunotherapy?","volume":"80","author":"Dunn","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.ccr.2025.216764_bb0225","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.nucmedbio.2016.07.006","article-title":"Paradoxical effects of Auger electron-emitting 111In-DTPA-NLS-CSL360 radioimmunoconjugates on hCD45+ cells in the bone marrow and spleen of leukemia-engrafted NOD\/SCID or NRG mice","volume":"43","author":"Bergstrom","year":"2016","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.ccr.2025.216764_bb0230","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/j.leukres.2014.09.005","article-title":"MicroSPECT\/CT imaging of primary human AML engrafted into the bone marrow and spleen of NOD\/SCID mice using 111In-DTPA-NLS-CSL360 radioimmunoconjugates recognizing the CD123+\/CD131\u2212 epitope expressed by leukemia stem cells","volume":"38","author":"Leyton","year":"2014","journal-title":"Leuk. Res."},{"key":"10.1016\/j.ccr.2025.216764_bb0235","doi-asserted-by":"crossref","first-page":"78","DOI":"10.2307\/3576869","article-title":"Kinetics of uptake, retention, and radiotoxicity of 125IUdR in mammalian cells: implications of localized energy deposition by Auger processes","volume":"109","author":"Kassis","year":"1987","journal-title":"Radiat. Res."},{"key":"10.1016\/j.ccr.2025.216764_bb0240","doi-asserted-by":"crossref","first-page":"797","DOI":"10.3109\/02841869609104029","article-title":"Strand breaks in plasmid DNA following positional changes of Auger-electron-emitting radionuclides","volume":"35","author":"Adelstein","year":"1996","journal-title":"Acta Oncol."},{"key":"10.1016\/j.ccr.2025.216764_bb0245","doi-asserted-by":"crossref","first-page":"401","DOI":"10.2307\/3579495","article-title":"Strand breaks after the decay of iodine-125 in proximity to plasmid pBR322 DNA","volume":"147","author":"Sahu","year":"1997","journal-title":"Radiat. Res."},{"key":"10.1016\/j.ccr.2025.216764_bb0250","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2307\/3579767","article-title":"Comparison of Strand breaks in plasmid DNA after positional changes of Auger electron-emitting iodine-125","volume":"151","author":"Kassis","year":"1999","journal-title":"Radiat. Res."},{"key":"10.1016\/j.ccr.2025.216764_bb0255","doi-asserted-by":"crossref","first-page":"998","DOI":"10.3109\/09553002.2012.706360","article-title":"Effect of distance between decaying 125I and DNA on Auger-electron induced double-strand break yield","volume":"88","author":"Balagurumoorthy","year":"2012","journal-title":"Int. J. Radiat. Biol."},{"key":"10.1016\/j.ccr.2025.216764_bb0260","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s10637-014-0086-5","article-title":"Evaluation of two 125I-radiolabeled acridine derivatives for Auger-electron radionuclide therapy of melanoma","volume":"32","author":"Gardette","year":"2014","journal-title":"Investig. New Drugs"},{"key":"10.1016\/j.ccr.2025.216764_bb0265","doi-asserted-by":"crossref","first-page":"441","DOI":"10.3390\/molecules26020441","article-title":"Synthesis and biological evaluation of 99mTc(I) tricarbonyl complexes dual-targeted at tumoral mitochondria","volume":"26","author":"Figueiredo","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.ccr.2025.216764_bb0270","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.freeradbiomed.2013.07.024","article-title":"Effects of ionizing radiation on mitochondria","volume":"65","author":"Kam","year":"2013","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ccr.2025.216764_bb0275","doi-asserted-by":"crossref","first-page":"7238","DOI":"10.3390\/ijms23137238","article-title":"Searching for a paradigm shift in Auger-electron cancer therapy with tumor-specific radiopeptides targeting the mitochondria and\/or the cell nucleus","volume":"23","author":"Fernandes","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ccr.2025.216764_bb0280","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1080\/09553007314551141","article-title":"The occurrence of double-strand breaks in coliphage T1-DNA by iodine-125 decay","volume":"24","author":"Schmidt","year":"1973","journal-title":"Int. J. Radiat. Biol. Relat. Stud. Phys. Chem. Med."},{"key":"10.1016\/j.ccr.2025.216764_bb0285","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1080\/09553007214550201","article-title":"Lethal effects of iodine-125 decay by electron capture in Escherichia Coli and in bacteriophage T1","volume":"21","author":"Krisch","year":"1972","journal-title":"Int. J. Radiat. Biol. Relat. Stud. Phys. Chem. Med."},{"key":"10.1016\/j.ccr.2025.216764_bb0290","doi-asserted-by":"crossref","first-page":"134","DOI":"10.2307\/3579922","article-title":"Indirect mechanisms contribute to biological effects produced by decay of DNA-incorporated iodine-125 in mammalian cells in vitro: double-strand breaks","volume":"149","author":"Walicka","year":"1998","journal-title":"Radiat. Res."},{"key":"10.1016\/j.ccr.2025.216764_bb0295","doi-asserted-by":"crossref","first-page":"332","DOI":"10.2307\/3574422","article-title":"The radiotoxicity of iodine-125 in mammalian cells: II. A comparative study on cell survival and cytogenetic responses to 125IUdR, 131IUdR, and 3HTdR","volume":"67","author":"Chan","year":"1976","journal-title":"Radiat. Res."},{"key":"10.1016\/j.ccr.2025.216764_bb0300","doi-asserted-by":"crossref","first-page":"532","DOI":"10.2307\/3577411","article-title":"Radiotoxicity of 5-[123I]iodo-2\u2032-deoxyuridine in V79 cells: a comparison with 5-[125I]iodo-2\u2032-deoxyuridine","volume":"118","author":"Makrigiorgos","year":"1989","journal-title":"Radiat. Res."},{"key":"10.1016\/j.ccr.2025.216764_bb0305","doi-asserted-by":"crossref","first-page":"305","DOI":"10.2307\/3576987","article-title":"Radiotoxicity of 125I in mammalian cells","volume":"111","author":"Kassis","year":"1987","journal-title":"Radiat. Res."},{"key":"10.1016\/j.ccr.2025.216764_bb0310","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1039\/D2CC05405A","article-title":"Hoechst-tagged radioiodinated BODIPY derivative for Auger-electron cancer therapy","volume":"59","author":"Onoue","year":"2023","journal-title":"Chem. Commun."},{"key":"10.1016\/j.ccr.2025.216764_bb0315","first-page":"386","article-title":"Intrathecal 5-[125I]iodo-2\u2032-deoxyuridine in a rat model of leptomeningeal metastases","volume":"38","author":"Sahu","year":"1997","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.ccr.2025.216764_bb0320","doi-asserted-by":"crossref","first-page":"3418","DOI":"10.1021\/acs.molpharmaceut.1c00323","article-title":"PARP-targeted Auger therapy in p53 mutant colon cancer xenograft mouse models","volume":"18","author":"Wilson","year":"2021","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ccr.2025.216764_bb0325","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.7150\/thno.15898","article-title":"Highly effective Auger-electron therapy in an orthotopic glioblastoma xenograft model using convection-enhanced delivery","volume":"6","author":"Thisgaard","year":"2016","journal-title":"Theranostics"},{"key":"10.1016\/j.ccr.2025.216764_bb0330","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1080\/09553000802395535","article-title":"First human treatment of resistant neoplastic meningitis by intrathecal administration of MTX plus 125IUdR","volume":"84","author":"Rebischung","year":"2008","journal-title":"Int. J. Radiat. Biol."},{"key":"10.1016\/j.ccr.2025.216764_bb0335","doi-asserted-by":"crossref","first-page":"8009","DOI":"10.3390\/molecules27228009","article-title":"Future prospective of radiopharmaceuticals from natural compounds using iodine radioisotopes as theranostic agents","volume":"27","author":"Nurhidayah","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.ccr.2025.216764_bb0340","first-page":"301","article-title":"Radiotoxicity of iodine-125 and other Auger-electron-emitting radionuclides: background to therapy","volume":"18","author":"Adelstein","year":"2004","journal-title":"Cancer Biother. Radiopharm."},{"key":"10.1016\/j.ccr.2025.216764_bb0345","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1021\/bc00009a008","article-title":"Backbone-substituted DTPA ligands for yttrium-90 radioimmunotherapy","volume":"2","author":"Brechbiel","year":"1994","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.ccr.2025.216764_bb0350","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1039\/c0cs00199f","article-title":"The synthesis and application of polyamino polycarboxylic bifunctional chelating agents","volume":"40","author":"Lattuada","year":"2011","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.ccr.2025.216764_bb0355","doi-asserted-by":"crossref","first-page":"8220","DOI":"10.1039\/c3cs60153f","article-title":"Be squared: expanding the horizon of squaric acid-mediated conjugations","volume":"42","author":"Wurm","year":"2013","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.ccr.2025.216764_bb0360","doi-asserted-by":"crossref","first-page":"3372","DOI":"10.1039\/D3SC06365H","article-title":"Tumor targeted alpha particle therapy with an actinium-225 labelled antibody for carbonic anhydrase IX","volume":"15","author":"Morgan","year":"2024","journal-title":"Chem. Sci."},{"key":"10.1016\/j.ccr.2025.216764_bb0365","doi-asserted-by":"crossref","first-page":"829","DOI":"10.2967\/jnumed.112.115550","article-title":"The growing impact of bioorthogonal click chemistry on the development of radiopharmaceuticals","volume":"54","author":"Zeng","year":"2013","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.ccr.2025.216764_bb0370","series-title":"Radiopharmaceutical Chemistry","first-page":"449","article-title":"Bioconjugation methods for radiopharmaceutical chemistry","author":"Cardinale","year":"2019"},{"key":"10.1016\/j.ccr.2025.216764_bb0375","doi-asserted-by":"crossref","first-page":"587","DOI":"10.2967\/jnumed.118.220806","article-title":"The impact of emerging bioconjugation chemistries on radiopharmaceuticals","volume":"60","author":"Fay","year":"2019","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.ccr.2025.216764_bb0380","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1039\/b309961j","article-title":"The role of coordination chemistry in the development of target-specific radiopharmaceuticals","volume":"33","author":"Liu","year":"2004","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.ccr.2025.216764_bb0385","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1021\/cr900325h","article-title":"Coordinating radiometals of copper, gallium, indium, yttrium, and zirconium for PET and SPECT imaging of disease","volume":"110","author":"Wadas","year":"2010","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ccr.2025.216764_bb0390","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.nucmedbio.2016.10.008","article-title":"Re-assessing gallium-67 as a therapeutic radionuclide","volume":"46","author":"Othman","year":"2017","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.ccr.2025.216764_bb0395","series-title":"Advances in Inorganic Chemistry","first-page":"1","article-title":"Chapter one - gallium: new developments and applications in radiopharmaceutics","author":"Blower","year":"2021"},{"key":"10.1016\/j.ccr.2025.216764_bb0400","doi-asserted-by":"crossref","first-page":"15702","DOI":"10.1039\/C5DT04706D","article-title":"Current advances in ligand design for inorganic positron emission tomography tracers 68Ga, 64Cu, 89Zr and 44Sc","volume":"45","author":"Price","year":"2016","journal-title":"Dalton Trans."},{"key":"10.1016\/j.ccr.2025.216764_bb0405","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1080\/14737159.2024.2383439","article-title":"[68Ga]PSMA-11 for positron emission tomography (PET) imaging of prostate-specific membrane antigen (PSMA)-positive lesions in men with prostate cancer","volume":"24","author":"Clore","year":"2024","journal-title":"Expert Rev. Mol. Diagn."},{"key":"10.1016\/j.ccr.2025.216764_bb0410","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S1383-5718(99)00221-1","article-title":"Assessment of radiation-induced DNA damage caused by the incorporation of 99mTc-radiopharmaceuticals in murine lymphocytes using single cell gel electrophoresis","volume":"465","author":"Pedraza-L\u00f3pez","year":"2000","journal-title":"Mutat. Res. Genet. Toxicol. Environ. Mutagen."},{"key":"10.1016\/j.ccr.2025.216764_bb0415","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1002\/cbic.200400210","article-title":"Induction of DNA-double-strand breaks by Auger electrons from 99mTc complexes with DNA-binding ligands","volume":"6","author":"H\u00e4fliger","year":"2005","journal-title":"ChemBioChem"},{"key":"10.1016\/j.ccr.2025.216764_bb0420","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1021\/bc0500084","article-title":"Cell uptake and radiotoxicity studies of an nuclear localization signal peptide\u2212intercalator conjugate labeled with [99mTc(CO)3]+","volume":"16","author":"Haefliger","year":"2005","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.ccr.2025.216764_bb0425","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3109\/09553000903564083","article-title":"99mTc Auger electrons for targeted tumour therapy: a review","volume":"86","author":"Tavares","year":"2010","journal-title":"Int. J. Radiat. Biol."},{"key":"10.1016\/j.ccr.2025.216764_bb0430","doi-asserted-by":"crossref","first-page":"698","DOI":"10.3109\/09553002.2016.1168533","article-title":"Comparison of the radiotoxicity of the 99mTc-labeled compounds 99mTc-Pertechnetate, 99mTc-HMPAO and 99mTc-MIBI","volume":"92","author":"Maucksch","year":"2016","journal-title":"Int. J. Radiat. Biol."},{"key":"10.1016\/j.ccr.2025.216764_bb0435","doi-asserted-by":"crossref","first-page":"13466","DOI":"10.3390\/ijms222413466","article-title":"Relationship of in vitro toxicity of technetium-99m to subcellular localisation and absorbed dose","volume":"22","author":"Costa","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ccr.2025.216764_bb0440","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1002\/bip.20129","article-title":"Benny, Mono-, bi-, or tridentate tridentate ligands? The labeling of peptides with 99mTc-carbonyls","volume":"76","author":"Alberto","year":"2004","journal-title":"J. Pept. Sci."},{"key":"10.1016\/j.ccr.2025.216764_bb0445","doi-asserted-by":"crossref","first-page":"277","DOI":"10.2174\/1874471010902040277","article-title":"Re and Tc complexes with pyrazolyl-containing chelators: from coordination chemistry to target-specific delivery of radioactivity","volume":"2","author":"Correia","year":"2009","journal-title":"Curr. Radiopharm."},{"key":"10.1016\/j.ccr.2025.216764_bb0450","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.2174\/156802610791384243","article-title":"99mTc and 111In-labeling of small biomolecules: bifunctional chelators and related coordination chemistry","volume":"10","author":"Chakraborty","year":"2010","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ccr.2025.216764_bb0455","doi-asserted-by":"crossref","first-page":"10755","DOI":"10.3390\/molecules190810755","article-title":"Metal complexes containing natural and artificial radioactive elements and their applications","volume":"19","author":"Kharissova","year":"2014","journal-title":"Molecules"},{"key":"10.1016\/j.ccr.2025.216764_bb0460","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1007\/s11094-015-1184-1","article-title":"Metal complexes with ethylenediaminedicarboxylic acids and their derivatives, promising pharmacological and diagnostic agents","volume":"48","author":"Tsirul\u2019nikova","year":"2015","journal-title":"Pharm. Chem. J."},{"key":"10.1016\/j.ccr.2025.216764_bb0465","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s10967-016-5019-7","article-title":"A review on evaluation of technetium-99m labeled radiopharmaceuticals","volume":"310","author":"Akbar","year":"2016","journal-title":"J. Radioanal. Nucl. Chem."},{"key":"10.1016\/j.ccr.2025.216764_bb0470","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1002\/jlcr.3531","article-title":"Technetium-99m radiochemistry for pharmaceutical applications","volume":"60","author":"Papagiannopoulou","year":"2017","journal-title":"J. Label. Compd. Radiopharm."},{"key":"10.1016\/j.ccr.2025.216764_bb0475","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.3390\/molecules23082039","article-title":"Technetium complexes and radiopharmaceuticals with scorpionate ligands","volume":"23","author":"Martini","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.ccr.2025.216764_bb0480","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.3390\/app9122526","article-title":"A picture of modern Tc-99m radiopharmaceuticals: production, chemistry, and applications in molecular imaging","volume":"9","author":"Boschi","year":"2019","journal-title":"Appl. Sci."},{"key":"10.1016\/j.ccr.2025.216764_bb0485","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1080\/00958972.2019.1632838","article-title":"Technetium-99m metastable radiochemistry for pharmaceutical applications: old chemistry for new products","volume":"72","author":"Costa","year":"2019","journal-title":"J. Coord. Chem."},{"key":"10.1016\/j.ccr.2025.216764_bb0490","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1515\/revic-2020-0021","article-title":"Recent advances in the synthesis of (99mtechnetium) based radio-pharmaceuticals","volume":"41","author":"Shahzad","year":"2021","journal-title":"Rev. Inorg. Chem."},{"key":"10.1016\/j.ccr.2025.216764_bb0495","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/s42004-024-01349-2","article-title":"Pivotal role of 99Tc NMR spectroscopy in solid-state and molecular chemistry","volume":"7","author":"Kuznetsov","year":"2024","journal-title":"Commun. Chem."},{"key":"10.1016\/j.ccr.2025.216764_bb0500","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1118\/1.597230","article-title":"Relative biological effectiveness of 99mTc radiopharmaceuticals","volume":"21","author":"Narra","year":"1994","journal-title":"Med. Phys."},{"key":"10.1016\/j.ccr.2025.216764_bb0505","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccr.2020.213375","article-title":"Pharmacological applications of non-radioactive indium(III) complexes: a field yet to be explored","volume":"419","author":"Beraldo","year":"2020","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.ccr.2025.216764_bb0510","first-page":"7","article-title":"ICRP publication 107. Nuclear decay data for dosimetric calculations","volume":"38","author":"Eckerman","year":"2008","journal-title":"Ann. ICRP"},{"key":"10.1016\/j.ccr.2025.216764_bb0515","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1006\/ndsh.1998.0021","article-title":"Nuclear data sheets for A=57","volume":"85","author":"Bhat","year":"1998","journal-title":"Nuclear Data Sheets"},{"key":"10.1016\/j.ccr.2025.216764_bb0520","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.nds.2010.03.003","article-title":"Nuclear data sheets for A=58","volume":"111","author":"Nesaraja","year":"2010","journal-title":"Nuclear Data Sheets"},{"key":"10.1016\/j.ccr.2025.216764_bb0525","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.nds.2005.10.006","article-title":"Nuclear data sheets for A=67","volume":"106","author":"Junde","year":"2005","journal-title":"Nuclear Data Sheets"},{"key":"10.1016\/j.ccr.2025.216764_bb0530","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1016\/j.nds.2009.08.002","article-title":"Nuclear data sheets for A=103","volume":"110","author":"De Frenne","year":"2009","journal-title":"Nuclear Data Sheets"},{"key":"10.1016\/j.ccr.2025.216764_bb0535","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1006\/ndsh.2002.0007","article-title":"Nuclear data sheets for A=117","volume":"95","author":"Blachot","year":"2002","journal-title":"Nuclear Data Sheets"},{"key":"10.1016\/j.ccr.2025.216764_bb0540","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1016\/j.nds.2009.10.003","article-title":"Nuclear data sheets for A=119","volume":"110","author":"Symochko","year":"2009","journal-title":"Nuclear Data Sheets"},{"key":"10.1016\/j.ccr.2025.216764_bb0545","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.nds.2008.02.001","article-title":"Nuclear data sheets for A=135","volume":"109","author":"Singh","year":"2008","journal-title":"Nuclear Data Sheets"},{"key":"10.1016\/j.ccr.2025.216764_bb0550","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nds.2019.100523","article-title":"Nuclear data sheets for A=155","volume":"160","author":"Nica","year":"2019","journal-title":"Nuclear Data Sheets"},{"key":"10.1016\/j.ccr.2025.216764_bb0555","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1016\/j.nds.2011.09.001","article-title":"Nuclear data sheets for A=161","volume":"112","author":"Reich","year":"2011","journal-title":"Nuclear Data Sheets"},{"key":"10.1016\/j.ccr.2025.216764_bb0560","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.nds.2024.04.002","article-title":"Nuclear data sheets for A=191","volume":"195","author":"Basunia","year":"2024","journal-title":"Nuclear Data Sheets"},{"key":"10.1016\/j.ccr.2025.216764_bb0565","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nds.2017.08.001","article-title":"Nuclear Data Sheets for A=193","volume":"143","author":"Basunia","year":"2017","journal-title":"Nuclear Data Sheets"},{"key":"10.1016\/j.ccr.2025.216764_bb0570","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.nds.2014.09.003","article-title":"Nuclear data sheets for A=195","volume":"121","author":"Huang","year":"2014","journal-title":"Nuclear Data Sheets"},{"key":"10.1016\/j.ccr.2025.216764_bb0575","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.nds.2005.01.001","article-title":"Nuclear data sheets for A=197","volume":"104","author":"Huang","year":"2005","journal-title":"Nuclear Data Sheets"},{"key":"10.1016\/j.ccr.2025.216764_bb0580","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.nds.2023.01.003","article-title":"Nuclear data sheets for A=201","volume":"187","author":"Kondev","year":"2023","journal-title":"Nuclear Data Sheets"},{"key":"10.1016\/j.ccr.2025.216764_bb0585","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.nds.2024.02.003","article-title":"Nuclear structure and decay data for A=165 isobars","volume":"194","author":"Singh","year":"2024","journal-title":"Nuclear Data Sheets"},{"key":"10.1016\/j.ccr.2025.216764_bb0590","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.nds.2011.03.001","article-title":"Nuclear data sheets for A=133","volume":"112","author":"Khazov","year":"2011","journal-title":"Nucl. Data Sheets"},{"key":"10.1016\/j.ccr.2025.216764_bb0595","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.nds.2005.03.001","article-title":"Nuclear data sheets for A=132","volume":"104","author":"Khazov","year":"2005","journal-title":"Nucl. Data Sheets"},{"key":"10.1016\/j.ccr.2025.216764_bb0600","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.nds.2011.02.001","article-title":"Nuclear data sheets for A=125","volume":"112","author":"Katakura","year":"2011","journal-title":"Nucl. Data Sheets"},{"key":"10.1016\/j.ccr.2025.216764_bb0605","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nds.2021.05.001","article-title":"Nuclear data sheets for A=123","volume":"174","author":"Chen","year":"2021","journal-title":"Nucl. Data Sheets"},{"key":"10.1016\/j.ccr.2025.216764_bb0610","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1006\/ndsh.2003.0016","article-title":"Nuclear data sheets for A=111","volume":"100","author":"Blachot","year":"2003","journal-title":"Nucl. Data Sheets"},{"key":"10.1016\/j.ccr.2025.216764_bb0615","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nds.2019.11.001","article-title":"Nuclear data sheets for A=105","volume":"161\u2013162","author":"Lalkovski","year":"2019","journal-title":"Nucl. Data Sheets"},{"key":"10.1016\/j.ccr.2025.216764_bb0620","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.nds.2017.09.002","article-title":"Nuclear data sheets for A=99","volume":"145","author":"Browne","year":"2017","journal-title":"Nuclear Data Sheets"},{"key":"10.1016\/j.ccr.2025.216764_bb0625","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nds.2018.08.001","article-title":"Nuclear data sheets for A=59","volume":"151","author":"Basunia","year":"2018","journal-title":"Nucl. Data Sheets"},{"key":"10.1016\/j.ccr.2025.216764_bb0630","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.nds.2008.03.001","article-title":"Nuclear data sheets for A=55","volume":"109","author":"Junde","year":"2008","journal-title":"Nucl. Data Sheets"},{"key":"10.1016\/j.ccr.2025.216764_bb0635","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.nds.2022.10.001","article-title":"Nuclear structure and decay data for A=149 isobars","volume":"185","author":"Singh","year":"2022","journal-title":"Nucl. Data Sheets"},{"key":"10.1016\/j.ccr.2025.216764_bb0640","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nds.2017.11.001","article-title":"Nuclear data sheets for A=138","volume":"146","author":"Chen","year":"2017","journal-title":"Nucl. Data Sheets"},{"key":"10.1016\/j.ccr.2025.216764_bb0645","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nds.2021.08.001","article-title":"Nuclear data sheets for A=160","volume":"176","author":"Nica","year":"2021","journal-title":"Nucl. Data Sheets"},{"key":"10.1016\/j.ccr.2025.216764_bb0650","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/j.nds.2013.11.001","article-title":"Nuclear data sheets for A=152","volume":"114","author":"Martin","year":"2013","journal-title":"Nucl. Data Sheets"},{"key":"10.1016\/j.ccr.2025.216764_bb0655","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/j.nds.2010.07.001","article-title":"Nuclear data sheets for A=168","volume":"111","author":"Baglin","year":"2010","journal-title":"Nucl. Data Sheets"},{"key":"10.1016\/j.ccr.2025.216764_bb0660","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nds.2023.08.001","article-title":"Nuclear structure and decay data for A=167 isobars","volume":"191","author":"Singh","year":"2023","journal-title":"Nucl. Data Sheets"},{"key":"10.1016\/j.ccr.2025.216764_bb0665","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.nds.2008.04.001","article-title":"Nuclear data sheets for A=166","volume":"109","author":"Baglin","year":"2008","journal-title":"Nucl. Data Sheets"},{"key":"10.1016\/j.ccr.2025.216764_bb0670","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s41181-024-00312-9","article-title":"First preclinical SPECT\/CT imaging and biodistribution of [165Er]ErCl3 and [165Er]Er-PSMA-617","volume":"9","author":"Saeedi Saghez","year":"2024","journal-title":"EJNMMI Radiopharm. Chem."},{"key":"10.1016\/j.ccr.2025.216764_bb0675","doi-asserted-by":"crossref","first-page":"4535","DOI":"10.1118\/1.3608905","article-title":"Production and dosimetric aspects of the potent Auger emitter 58mCo for targeted radionuclide therapy of small tumors","volume":"38","author":"Thisgaard","year":"2011","journal-title":"Med. Phys."},{"key":"10.1016\/j.ccr.2025.216764_bb0680","doi-asserted-by":"crossref","DOI":"10.1063\/1.4954126","article-title":"Auger electron-based targeted radioimmunotherapy with 58mCo, a feasibility study","volume":"1747","author":"Valdovinos","year":"2016","journal-title":"AIP Conf. Proc."},{"key":"10.1016\/j.ccr.2025.216764_bb0685","series-title":"Multinuclear NMR","first-page":"521","article-title":"Appendix: NMR Properties of the Elements","author":"Mason","year":"1987"},{"key":"10.1016\/j.ccr.2025.216764_bb0690","series-title":"Multinuclear NMR","first-page":"521","article-title":"Group VIII Transition Metals","author":"Goodfellow","year":"1987"},{"key":"10.1016\/j.ccr.2025.216764_bb0695","doi-asserted-by":"crossref","first-page":"14618","DOI":"10.1021\/jp9614254","article-title":"Cobalt-59 nuclear magnetic relaxation studies of aqueous octahedral cobalt(III) complexes","volume":"100","author":"Kirby","year":"1996","journal-title":"J. Phys. Chem."},{"key":"10.1016\/j.ccr.2025.216764_bb0700","doi-asserted-by":"crossref","first-page":"6727","DOI":"10.1039\/C9SC01689A","article-title":"Influence of ligand encapsulation on cobalt-59 chemical-shift thermometry","volume":"10","author":"Ozvat","year":"2019","journal-title":"Chem. Sci."},{"key":"10.1016\/j.ccr.2025.216764_bb0705","doi-asserted-by":"crossref","first-page":"9132","DOI":"10.1021\/jacs.2c03115","article-title":"Record chemical-shift temperature sensitivity in a series of trinuclear cobalt complexes","volume":"144","author":"\u00dcng\u00f6r","year":"2022","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ccr.2025.216764_bb0710","doi-asserted-by":"crossref","first-page":"7064","DOI":"10.1039\/D3QI01641B","article-title":"Asymmetry-enhanced 59Co NMR thermometry in Co(III) complexes","volume":"10","author":"\u00dcng\u00f6r","year":"2023","journal-title":"Inorg. Chem. Front."},{"key":"10.1016\/j.ccr.2025.216764_bb0715","doi-asserted-by":"crossref","first-page":"3026","DOI":"10.1002\/chem.200701264","article-title":"Metal-ion-dependent biological properties of a chelator-derived somatostatin analogue for tumour targeting","volume":"14","author":"Heppeler","year":"2008","journal-title":"Chem. Eur. J."},{"key":"10.1016\/j.ccr.2025.216764_bb0720","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.3390\/diagnostics11071235","article-title":"Production, purification, and applications of a potential theranostic pair: cobalt-55 and cobalt-58m","volume":"11","author":"Barrett","year":"2021","journal-title":"Diagnostics"},{"key":"10.1016\/j.ccr.2025.216764_bb0725","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0022-1902(77)80001-8","article-title":"On the survival of Co(III) complexes to deexcitation by internal conversion of the 58mCo coordinating atom","volume":"39","author":"Lazzarini","year":"1977","journal-title":"J. Inorg. Nucl. Chem."},{"key":"10.1016\/j.ccr.2025.216764_bb0730","doi-asserted-by":"crossref","first-page":"308","DOI":"10.13182\/NSE61-A15372","article-title":"Cross sections of threshold reactions for fission neutrons: nickel as a fast flux monitor","volume":"10","author":"Passell","year":"1961","journal-title":"Nucl. Sci. Eng."},{"key":"10.1016\/j.ccr.2025.216764_bb0735","doi-asserted-by":"crossref","DOI":"10.1016\/j.apradiso.2023.110980","article-title":"Separation of cyclotron-produced cobalt-55\/58m from iron targets using cation exchange chromatography with non-aqueous solvents and extraction chromatography","volume":"200","author":"Lin","year":"2023","journal-title":"Appl. Radiat. Isot."},{"key":"10.1016\/j.ccr.2025.216764_bb0740","article-title":"Production of Co-58m in a siphon-style liquid target on a medical cyclotron","volume":"195","author":"Koers","year":"2023","journal-title":"Appl. Radiat. Isot."},{"key":"10.1016\/j.ccr.2025.216764_bb0745","series-title":"Advanced Inorganic Chemistry","author":"Cotton","year":"1999"},{"key":"10.1016\/j.ccr.2025.216764_bb0750","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1107\/S0567739476001551","article-title":"Revised effective ionic radii and systematic studies of interatomic distances in halides and chalcogenides","volume":"A32","author":"Shannon","year":"1976","journal-title":"Acta Cryst"},{"key":"10.1016\/j.ccr.2025.216764_bb0755","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1021\/ic00277a030","article-title":"Absolute electronegativity and hardness: application to inorganic chemistry","volume":"27","author":"Pearson","year":"1988","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.ccr.2025.216764_bb0760","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinorgbio.2020.111041","article-title":"Bioconjugates of Co(III) complexes with Schiff base ligands and cell penetrating peptides: solid phase synthesis, characterization and antiproliferative activity","volume":"206","author":"\u015ami\u0142owicz","year":"2020","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.ccr.2025.216764_bb0765","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ica.2015.11.016","article-title":"Assessing the stability of the Co(I) species of two mononuclear dichlorocobalt compounds bearing 2,2\u2032-bipyridine and trans-2-(2\u2032-quiolyl)methylene-3-quinuclidione via 59Co NMR spectroscopy, electrochemical, and catalyzed proton electroreduction studies","volume":"441","author":"Lawrence","year":"2016","journal-title":"Inorg. Chim. Acta"},{"key":"10.1016\/j.ccr.2025.216764_bb0770","doi-asserted-by":"crossref","first-page":"6767","DOI":"10.1039\/C8DT03696A","article-title":"Exploring transition metal fluoride chelates \u2013 synthesis, properties and prospects towards potential PET probes","volume":"48","author":"Blower","year":"2019","journal-title":"Dalton Trans."},{"key":"10.1016\/j.ccr.2025.216764_bb0775","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1021\/acs.inorgchem.9b02864","article-title":"Cobalt(III) metallacryptates and their guest cation-exchange in solution monitored by 59Co NMR","volume":"59","author":"Pham","year":"2020","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.ccr.2025.216764_bb0780","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0162-0134(95)97327-M","article-title":"Irreversible enzymatic inhibition by cobalt chelate complexes","volume":"59","author":"B\u00f6ttcher","year":"1995","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.ccr.2025.216764_bb0785","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.3390\/ph3061711","article-title":"Cobalt complexes as antiviral and antibacterial agents","volume":"3","author":"Chang","year":"2010","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ccr.2025.216764_bb0790","doi-asserted-by":"crossref","DOI":"10.1016\/j.poly.2022.115890","article-title":"A concise review on cobalt Schiff base complexes as anticancer agents","volume":"222","author":"Kar","year":"2022","journal-title":"Polyhedron"},{"key":"10.1016\/j.ccr.2025.216764_bb0795","doi-asserted-by":"crossref","first-page":"6609","DOI":"10.1021\/acs.inorgchem.7b00710","article-title":"Bis(thiosemicarbazone) complexes of cobalt(III). Synthesis, characterization, and anticancer potential","volume":"56","author":"King","year":"2017","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.ccr.2025.216764_bb0800","doi-asserted-by":"crossref","first-page":"6161","DOI":"10.1039\/D1CC01623G","article-title":"Cobalt amine complexes and Ru265 interact with the DIME region of the mitochondrial calcium uniporter","volume":"57","author":"Woods","year":"2021","journal-title":"Chem. Commun."},{"key":"10.1016\/j.ccr.2025.216764_bb0805","doi-asserted-by":"crossref","DOI":"10.1002\/ejic.202200735","article-title":"Investigation of cobalt(III) cage complexes as inhibitors of the mitochondrial calcium uniporter","volume":"26","author":"Bigham","year":"2023","journal-title":"Eur. J. Inorg. Chem."},{"key":"10.1016\/j.ccr.2025.216764_bb0810","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.cbpa.2012.11.019","article-title":"Cobalt derivatives as promising therapeutic agents","volume":"17","author":"Heffern","year":"2013","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.ccr.2025.216764_bb0815","series-title":"Essential Metals in Medicine: Therapeutic Use and Toxicity of Metal Ions in the Clinic","first-page":"267","article-title":"Cobalt-Schiff base complexes: preclinical research and potential therapeutic uses","author":"Bajema","year":"2019"},{"key":"10.1016\/j.ccr.2025.216764_bb0820","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1021\/ic961146v","article-title":"Spectroscopy and electrochemistry of cobalt(III) Schiff base complexes","volume":"36","author":"B\u00f6ttcher","year":"1997","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.ccr.2025.216764_bb0825","doi-asserted-by":"crossref","first-page":"4117","DOI":"10.1128\/JVI.75.9.4117-4128.2001","article-title":"Herpes simplex virus type 1 entry is inhibited by the cobalt chelate complex CTC-96","volume":"75","author":"Schwartz","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.ccr.2025.216764_bb0830","first-page":"327","article-title":"A Retrospective of Cobalt-60 Radiation Therapy: \u201cThe Atom Bomb That Saves Lives\u201d","author":"Van Dyk","year":"2020","journal-title":"Med. Phys. Int. (MPI) History of Medical Physics"},{"key":"10.1016\/j.ccr.2025.216764_bb0835","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3390\/molecules30020212","article-title":"Radiocobalt-labeling of a polypyridylamine chelate conjugated to GE11 for EGFR-targeted theranostics","volume":"30","author":"G\u00e9","year":"2025","journal-title":"Molecules"},{"key":"10.1016\/j.ccr.2025.216764_bb0840","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/hlca.19770600115","article-title":"Pyridinderivate als Komplexbildner. XI. Die Thermodynamik der Metallkomplexbildung mit Bis-, Tris- und Tetrakis[(2-pyridyl)methyl]-aminen","volume":"60","author":"Anderegg","year":"1977","journal-title":"Helv. Chim. Acta"},{"key":"10.1016\/j.ccr.2025.216764_bb0845","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1096\/fj.05-4058com","article-title":"Identification and characterization of a novel peptide ligand of epidermal growth factor receptor for targeted delivery of therapeutics","volume":"19","author":"Li","year":"2005","journal-title":"FASEB J."},{"key":"10.1016\/j.ccr.2025.216764_bb0850","doi-asserted-by":"crossref","DOI":"10.1016\/j.poly.2020.114731","article-title":"Influence of the flexible tetrapyridines on electrocatalytic water oxidation by cobalt complexes","volume":"189","author":"Xie","year":"2020","journal-title":"Polyhedron"},{"key":"10.1016\/j.ccr.2025.216764_bb0855","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202412357","article-title":"Controlling the redox chemistry of cobalt radiopharmaceuticals","volume":"63","author":"Lin","year":"2024","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ccr.2025.216764_bb0860","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.2967\/jnumed.113.130898","article-title":"Development of a radiolabeled irreversible peptide ligand for PET imaging of vascular endothelial growth factor","volume":"55","author":"Marquez","year":"2014","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.ccr.2025.216764_bb0865","doi-asserted-by":"crossref","DOI":"10.2310\/7290.2015.00025","article-title":"Cyclotron production of high-specific activity 55Co and in vivo evaluation of the stability of 55Co metal-chelate-peptide complexes","volume":"14","author":"Mastren","year":"2015","journal-title":"Mol. Imaging"},{"key":"10.1016\/j.ccr.2025.216764_bb0870","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1002\/jlcr.1919","article-title":"Radiosynthesis of 55Co- and 58mCo-labelled DOTATOC for positron emission tomography imaging and targeted radionuclide therapy","volume":"54","author":"Thisgaard","year":"2011","journal-title":"J. Label. Compd. Radiopharm."},{"key":"10.1016\/j.ccr.2025.216764_bb0875","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.2967\/jnumed.114.137182","article-title":"Evaluation of cobalt-labeled octreotide analogs for molecular imaging and Auger electron\u2013based radionuclide therapy","volume":"55","author":"Thisgaard","year":"2014","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.ccr.2025.216764_bb0880","series-title":"Critical Survey of Stability Constants of EDTA Complexes","first-page":"1","article-title":"Critical survey of stability constants of EDTA complexes","author":"Anderegg","year":"1977"},{"key":"10.1016\/j.ccr.2025.216764_bb0885","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1351\/pac200577081445","article-title":"Critical evaluation of stability constants of metal complexes of complexones for biomedical and environmental applications","volume":"77","author":"Anderegg","year":"2005","journal-title":"Pure Appl. Chem."},{"key":"10.1016\/j.ccr.2025.216764_bb0890","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/s00262-005-0691-4","article-title":"Antiangiogenic chimeric anti-endoglin (CD105) antibody: pharmacokinetics and immunogenicity in nonhuman primates and effects of doxorubicin","volume":"55","author":"Shiozaki","year":"2006","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.ccr.2025.216764_bb0895","doi-asserted-by":"crossref","first-page":"7898","DOI":"10.1073\/pnas.83.20.7898","article-title":"Distinct human leukemia-associated cell surface glycoprotein GP160 defined by monoclonal antibody SN6","volume":"83","author":"Haruta","year":"1986","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ccr.2025.216764_bb0900","doi-asserted-by":"crossref","first-page":"8361","DOI":"10.1016\/S0021-9258(19)38892-1","article-title":"Primary structure of endoglin, an RGD-containing glycoprotein of human endothelial cells","volume":"265","author":"Gougos","year":"1990","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ccr.2025.216764_bb0905","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1002\/jcb.21594","article-title":"Novel biochemical pathways of endoglin in vascular cell physiology","volume":"102","author":"Bernabeu","year":"2007","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.ccr.2025.216764_bb0910","first-page":"135","article-title":"Endoglin-targeted cancer therapy","volume":"8","author":"Seon","year":"2011","journal-title":"Curr. Drug Discov."},{"key":"10.1016\/j.ccr.2025.216764_bb0915","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3390\/ijms22010147","article-title":"Endoglin targeting: lessons learned and questions that remain","volume":"22","author":"Liu","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ccr.2025.216764_bb0920","doi-asserted-by":"crossref","first-page":"17086","DOI":"10.1038\/s41598-019-52914-y","article-title":"Selection of an optimal macrocyclic chelator improves the imaging of prostate cancer using cobalt-labeled GRPR antagonist RM26","volume":"9","author":"Mitran","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ccr.2025.216764_bb0925","doi-asserted-by":"crossref","first-page":"10546","DOI":"10.1021\/jacs.8b05685","article-title":"19F PARASHIFT probes for magnetic resonance detection of H2O2 and peroxidase activity","volume":"140","author":"Yu","year":"2018","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ccr.2025.216764_bb0930","doi-asserted-by":"crossref","first-page":"13997","DOI":"10.1002\/anie.201306394","article-title":"A redox-activated MRI contrast agent that switches between paramagnetic and diamagnetic states","volume":"52","author":"Tsitovich","year":"2013","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ccr.2025.216764_bb0935","doi-asserted-by":"crossref","first-page":"15613","DOI":"10.1021\/ja2052599","article-title":"Factors influencing the DNA nuclease activity of iron, cobalt, nickel, and copper chelates","volume":"133","author":"Joyner","year":"2011","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ccr.2025.216764_bb0940","doi-asserted-by":"crossref","first-page":"9912","DOI":"10.1021\/ja203057z","article-title":"Targeted cleavage of HIV RRE RNA by rev-coupled transition metal chelates","volume":"133","author":"Joyner","year":"2011","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ccr.2025.216764_bb0945","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1021\/acs.bioconjchem.4c00043","article-title":"Radiolabeling diaminosarcophagine with cyclotron-produced cobalt-55 and [55Co]Co-NT-Sarcage as a proof of concept in a murine xenograft model","volume":"35","author":"Lin","year":"2024","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.ccr.2025.216764_bb0950","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/S0022-3565(24)36482-1","article-title":"Biochemical and pharmacological activities of SR 142948A, a new potent neurotensin receptor antagonist","volume":"280","author":"Gully","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ccr.2025.216764_bb0955","series-title":"Synthesis and radiolabeling of a somatostatin analog for multimodal imaging, in: Proc. of SPIE","first-page":"609703","author":"Edwards","year":"2006"},{"key":"10.1016\/j.ccr.2025.216764_bb0960","first-page":"296P","article-title":"Formulation comparisons and pharmacokinetics of high specific activity ultratrace 131I-iobenguane (mIBG) for therapy","volume":"48","author":"Kronauge","year":"2007","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.ccr.2025.216764_bb0965","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2174\/1874471008666150313111633","article-title":"Lutetium-177 labeled peptides: the European Institute of Oncology Experience","volume":"9","author":"Carollo","year":"2016","journal-title":"Curr. Radiopharm."},{"key":"10.1016\/j.ccr.2025.216764_bb0970","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1524\/ract.1970.13.3.134","article-title":"Abtrennung von 103mRh von 103Pd in Form eines Isotopengenerators","volume":"13","author":"Bernhard","year":"1970","journal-title":"Radiochim. Acta"},{"key":"10.1016\/j.ccr.2025.216764_bb0975","first-page":"772","article-title":"Rhodium-103m generator","volume":"20","author":"Mamadaliev","year":"1978","journal-title":"Radiokhimiya"},{"key":"10.1016\/j.ccr.2025.216764_bb0980","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s10967-009-0529-1","article-title":"Production of 103mRh for cancer therapy","volume":"280","author":"Skarnemark","year":"2009","journal-title":"J. Radioanal. Nucl. Chem."},{"key":"10.1016\/j.ccr.2025.216764_bb0985","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s10967-008-7346-9","article-title":"103Ru\/103mRh generator","volume":"279","author":"Barto\u015b","year":"2009","journal-title":"J. Radioanal. Nucl. Chem."},{"key":"10.1016\/j.ccr.2025.216764_bb0990","doi-asserted-by":"crossref","DOI":"10.1016\/j.apradiso.2019.108985","article-title":"A solid support generator of the Auger electron emitter rhodium-103m from [103Pd]palladium","volume":"156","author":"Jensen","year":"2020","journal-title":"Appl. Radiat. Isot."},{"key":"10.1016\/j.ccr.2025.216764_bb0995","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1515\/ract-2023-0238","article-title":"Production of Auger-electron-emitting 103mRh via a 103Pd\/103mRh generator using an anion-exchange resin","volume":"112","author":"Ohya","year":"2024","journal-title":"Radiochim. Acta"},{"key":"10.1016\/j.ccr.2025.216764_bb1000","series-title":"Encyclopedia of Inorganic Chemistry","article-title":"Rhodium: Inorganic & Coordination Chemistry","author":"Jardine","year":"2005"},{"key":"10.1016\/j.ccr.2025.216764_bb1005","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1021\/ed073p654","article-title":"Hard and soft acid-base behavior in aqueous solution: steric effects make some metal ions hard: a quantitative scale of hardness-softness for acids and bases","volume":"73","author":"Hancock","year":"1996","journal-title":"J. Chem. Educ."},{"key":"10.1016\/j.ccr.2025.216764_bb1010","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1021\/ic00113a025","article-title":"Slow proton exchange kinetics in aqueous solutions of hexaaquarhodium(III): influence of the second hydration sphere","volume":"34","author":"Banyai","year":"1995","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.ccr.2025.216764_bb1015","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1002\/mrc.1439","article-title":"103Rh NMR spectroscopy and its application to rhodium chemistry","volume":"42","author":"Ernsting","year":"2004","journal-title":"Magn. Reson. Chem."},{"key":"10.1016\/j.ccr.2025.216764_bb1020","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1021\/bc00003a003","article-title":"Labeling of human IgG with rhodium-105 using a new pentadentate bifunctional ligand","volume":"1","author":"Pillai","year":"1990","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.ccr.2025.216764_bb1025","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/0883-2889(89)90081-6","article-title":"Labeling of proteins with 105Rh","volume":"40","author":"John","year":"1989","journal-title":"Int. J. Rad. Appl. Instr. A"},{"key":"10.1016\/j.ccr.2025.216764_bb1030","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/0883-2897(90)90111-D","article-title":"Labeling of proteins using [105Rh]Rh-4-(p-aminobenzyl)-diethylenetriamine","volume":"17","author":"Pillai","year":"1990","journal-title":"Int. J. Rad. Appl. Instr. B"},{"key":"10.1016\/j.ccr.2025.216764_bb1035","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1524\/ract.1999.85.34.157","article-title":"Preparation of 105Rh labeled monoclonal antibody (MAb B72.3) using aminobenzylpropyleneamineoxime as the bifunctional chelating agent; comparison to 131I labeled MAb B72.3","volume":"85","author":"Venkatesh","year":"1999","journal-title":"Radiochim. Acta"},{"key":"10.1016\/j.ccr.2025.216764_bb1040","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0883-2889(90)90132-Z","article-title":"Labeling of hematoporphyrin with 105Rh and binding studies with human gamma globulin","volume":"41","author":"Pillai","year":"1990","journal-title":"Int. J. Rad. Appl. Instr. A"},{"key":"10.1016\/j.ccr.2025.216764_bb1045","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0883-2889(90)90131-Y","article-title":"Labeling of human serum albumin with 105Rh\u2013cysteine complexes","volume":"41","author":"Lo","year":"1990","journal-title":"Int. J. Rad. Appl. Instr. A"},{"key":"10.1016\/j.ccr.2025.216764_bb1050","doi-asserted-by":"crossref","first-page":"14677","DOI":"10.1039\/C7DT02407J","article-title":"Chemistry and radiochemistry of As, Re and Rh isotopes relevant to radiopharmaceutical applications: high specific activity radionuclides for imaging and treatment","volume":"46","author":"Feng","year":"2017","journal-title":"Dalton Trans."},{"key":"10.1016\/j.ccr.2025.216764_bb1055","doi-asserted-by":"crossref","first-page":"10169","DOI":"10.1039\/c0dt00813c","article-title":"The complexation of rhodium(III) with acyclic diaminedithioether (DADTE) ligands","volume":"39","author":"Akgun","year":"2010","journal-title":"Dalton Trans."},{"key":"10.1016\/j.ccr.2025.216764_bb1060","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1021\/ic50015a011","article-title":"Catalysis of substitution reactions of rhodium(III) complexes. The reaction of aquopentachlororhodate(III) ion with pyridine","volume":"3","author":"Rund","year":"1964","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.ccr.2025.216764_bb1065","doi-asserted-by":"crossref","first-page":"7546","DOI":"10.1021\/ic960952z","article-title":"Rhodium(III) complexes with acyclic tetrathioether ligands. Effects of backbone chain length on the conformation of the Rh(III) complex","volume":"35","author":"Goswami","year":"1996","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.ccr.2025.216764_bb1070","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0969-8051(99)00070-0","article-title":"Rhodium-105 tetrathioether complexes: radiochemistry and initial biological evaluation","volume":"26","author":"Goswami","year":"1999","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.ccr.2025.216764_bb1075","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/MED.0b013e3282f3709b","article-title":"Bombesin-related peptides and their receptors: recent advances in their role in physiology and disease states","volume":"15","author":"Gonzalez","year":"2008","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"10.1016\/j.ccr.2025.216764_bb1080","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.nucmedbio.2010.06.013","article-title":"Tetradentate bis-phosphine ligands (P2N2 and P2S2) and their Rh(III), Ni(II) and 105Rh complexes: X-ray crystal structures of trans-[RhCl2(L2)]PF6, [Ni(L2)](PF6)2 and \u03bc-O2SO2-[Ni(L5)]2(PF6)2","volume":"38","author":"Cagnolini","year":"2011","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.ccr.2025.216764_bb1085","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1080\/10426509908546286","article-title":"Rhodium-105 complexes of polydentate, aqueous-soluble, phosphine ligands: new radiochemical developments towards radioimmunotherapy, phosphorus, sulfur","volume":"144","author":"Smith","year":"1999","journal-title":"Silicon Relat. Elem."},{"key":"10.1016\/j.ccr.2025.216764_bb1090","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0969-8051(95)02012-8","article-title":"An Rh-105 complex of tetrathiacyclohexadecane diol with potential for formulating bifunctional chelates","volume":"23","author":"Venkatesh","year":"1996","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.ccr.2025.216764_bb1095","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1524\/ract.1996.75.2.83","article-title":"Comparisons of 105Rh(III) chloride complexation with [14]aneNS3, [14]aneN2S2 and [14]aneN4 macrocycles in aqueous solution","volume":"75","author":"Li","year":"1996","journal-title":"Radiochim. Acta"},{"key":"10.1016\/j.ccr.2025.216764_bb1100","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0969-8051(96)00177-1","article-title":"Biodistribution of model 105Rh-labeled tetradentate thiamacrocycles in rats","volume":"24","author":"Li","year":"1997","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.ccr.2025.216764_bb1105","doi-asserted-by":"crossref","first-page":"4603","DOI":"10.3390\/molecules26154603","article-title":"Novel bifunctional [16]aneS4-derived chelators for soft radiometals","volume":"26","author":"Straathof","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.ccr.2025.216764_bb1110","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1080\/028418601750444141","article-title":"Low-energy electron emitters for targeted radiotherapy of small tumours","volume":"40","author":"Bernhardt","year":"2001","journal-title":"Acta Oncol."},{"key":"10.1016\/j.ccr.2025.216764_bb1115","doi-asserted-by":"crossref","first-page":"15223","DOI":"10.1021\/acs.inorgchem.1c01690","article-title":"A third generation potentially bifunctional trithiol chelate, its nat,1XXSb(III) complex, and selective chelation of radioantimony (119Sb) from its Sn target","volume":"60","author":"Olson","year":"2021","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.ccr.2025.216764_bb1120","doi-asserted-by":"crossref","DOI":"10.1002\/cplu.202400250","article-title":"Chemistry of antimony in radiopharmaceutical development: unlocking the theranostic potential of Sb isotopes","volume":"89","author":"Grundmane","year":"2024","journal-title":"ChemPlusChem"},{"key":"10.1016\/j.ccr.2025.216764_bb1125","doi-asserted-by":"crossref","first-page":"3839","DOI":"10.1118\/1.2963993","article-title":"119Sb\u2014a potent Auger emitter for targeted radionuclide therapy","volume":"35","author":"Thisgaard","year":"2008","journal-title":"Med. Phys."},{"key":"10.1016\/j.ccr.2025.216764_bb1130","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.apradiso.2008.09.003","article-title":"Production of the Auger emitter 119Sb for targeted radionuclide therapy using a small PET-cyclotron","volume":"67","author":"Thisgaard","year":"2009","journal-title":"Appl. Radiat. Isot."},{"key":"10.1016\/j.ccr.2025.216764_bb1135","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1021\/acscentsci.8b00869","article-title":"Large-scale production of 119mTe and 119Sb for radiopharmaceutical applications","volume":"5","author":"Bennett","year":"2019","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.ccr.2025.216764_bb1140","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.nimb.2017.08.038","article-title":"Cross sections for proton-induced reactions on natSb up to 68 MeV","volume":"412","author":"Mosby","year":"2017","journal-title":"Nucl. Inst. Methods Phys. Res. B"},{"key":"10.1016\/j.ccr.2025.216764_bb1145","series-title":"Encyclopedia of Inorganic and Bioinorganic Chemistry","first-page":"1","article-title":"Antimony: Inorganic Chemistry","author":"Fischer","year":"2016"},{"key":"10.1016\/j.ccr.2025.216764_bb1150","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1021\/ja00905a001","article-title":"Hard and soft acids and bases","volume":"85","author":"Pearson","year":"1963","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ccr.2025.216764_bb1155","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1021\/ed045p581","article-title":"Hard and soft acids and bases, HSAB, part 1: fundamental principles","volume":"45","author":"Pearson","year":"1968","journal-title":"J. Chem. Educ."},{"key":"10.1016\/j.ccr.2025.216764_bb1160","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1021\/ed045p643","article-title":"Hard and soft acids and bases, HSAB, part II: underlying theories","volume":"45","author":"Pearson","year":"1968","journal-title":"J. Chem. Educ."},{"key":"10.1016\/j.ccr.2025.216764_bb1165","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.cplett.2007.07.015","article-title":"Cluster size effect on the electric polarizability and hyperpolarizability in small antimony clusters SbNn, n=1,2 and 4","volume":"444","author":"Maroulis","year":"2007","journal-title":"Chem. Phys. Lett."},{"key":"10.1016\/j.ccr.2025.216764_bb1170","series-title":"Encyclopedia of Inorganic and Bioinorganic Chemistry","first-page":"1","article-title":"Emerging therapeutic radiopharmaceuticals and their theranostic pairs","author":"Carbo-Bague","year":"2021"},{"key":"10.1016\/j.ccr.2025.216764_bb1175","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2020.115156","article-title":"Antimony and its compounds: health impacts related to pulmonary toxicity, cancer, and genotoxicity","volume":"403","author":"Boreiko","year":"2020","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.ccr.2025.216764_bb1180","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1016\/S1003-6326(16)64370-4","article-title":"Theoretical simulation and experimental study of hydrolysis separation of SbCl3 in complexation\u2013precipitation system","volume":"26","author":"Tian","year":"2016","journal-title":"Trans. Nonferrous Metals Soc. China"},{"key":"10.1016\/j.ccr.2025.216764_bb1185","series-title":"Radiation Biophysics","first-page":"104","article-title":"Radiation chemistry","author":"Alpen","year":"1998"},{"key":"10.1016\/j.ccr.2025.216764_bb1190","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1021\/es035019r","article-title":"Kinetic studies on Sb(III) oxidation by hydrogen peroxide in aqueous solution","volume":"38","author":"Quentel","year":"2004","journal-title":"Environ. Sci. Technol."},{"key":"10.1016\/j.ccr.2025.216764_bb1195","doi-asserted-by":"crossref","DOI":"10.1016\/j.snb.2019.127454","article-title":"Simultaneous electrochemical determination of Sb(III) and Sb(V) in water samples: deposition potential differences and Sb(III) photooxidation characteristics","volume":"305","author":"Shan","year":"2020","journal-title":"Sensors Actuators B Chem."},{"key":"10.1016\/j.ccr.2025.216764_bb1200","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004304","article-title":"Antimony to cure visceral Leishmaniasis unresponsive to liposomal amphotericin B","author":"Morizot","year":"2016","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.ccr.2025.216764_bb1205","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jinorgbio.2015.06.006","article-title":"Recent advances on antimony(III\/V) compounds with potential activity against tumor cells","volume":"153","author":"Hadjikakou","year":"2012","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.ccr.2025.216764_bb1210","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1021\/ar600001b","article-title":"Bioinorganic chemistry of bismuth and antimony: target sites of metallodrugs","volume":"40","author":"Ge","year":"2007","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.ccr.2025.216764_bb1215","doi-asserted-by":"crossref","first-page":"4260","DOI":"10.1002\/1521-3773(20001201)39:23<4260::AID-ANIE4260>3.0.CO;2-9","article-title":"Complexation of antimony(III) by trypanothione","volume":"39","author":"Yan","year":"2000","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ccr.2025.216764_bb1220","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S1040-8428(01)00217-7","article-title":"Antimony and bismuth compounds in oncology","volume":"42","author":"Tiekink","year":"2002","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.ccr.2025.216764_bb1225","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1111\/j.1745-7254.2008.00818.x","article-title":"Perspectives of antimony compounds in oncology","volume":"29","author":"Sharma","year":"2008","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ccr.2025.216764_bb1230","doi-asserted-by":"crossref","first-page":"5450","DOI":"10.1046\/j.1432-1327.2000.01605.x","article-title":"Interaction of antimony tartrate with the tripeptide glutathione","volume":"267","author":"Sun","year":"2000","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.ccr.2025.216764_bb1235","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0009-8981(03)00200-6","article-title":"Analysis of glutathione: implication in redox and detoxification","volume":"333","author":"Pastore","year":"2003","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ccr.2025.216764_bb1240","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1039\/b511453e","article-title":"Critical appraisal of available thermodynamic data for the complexation of antimony(III) and antimony(V) by low molecular mass organic ligands","volume":"7","author":"Filella","year":"2005","journal-title":"J. Environ. Monit."},{"key":"10.1016\/j.ccr.2025.216764_bb1245","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s00775-003-0468-1","article-title":"Reduction of pentavalent antimony by trypanothione and formation of a binary and ternary complex of antimony(III) and trypanothione","volume":"8","author":"Yan","year":"2003","journal-title":"J. Biol. Inorg. Chem."},{"key":"10.1016\/j.ccr.2025.216764_bb1250","doi-asserted-by":"crossref","first-page":"509","DOI":"10.3891\/acta.chem.scand.22-0509","article-title":"The molecular and crystal structure of antimony hydrogen bis(thioglycollate)","volume":"22","author":"Hansson","year":"1968","journal-title":"Acta Chem. Scand."},{"key":"10.1016\/j.ccr.2025.216764_bb1255","doi-asserted-by":"crossref","first-page":"14253","DOI":"10.1021\/acs.inorgchem.1c01765","article-title":"Exploring cyclic aminopolycarboxylate ligands for Sb(III) complexation: PCTA and its derivatives as a promising solution","volume":"60","author":"T\u00f3th-Moln\u00e1r","year":"2021","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.ccr.2025.216764_bb1260","doi-asserted-by":"crossref","first-page":"4374","DOI":"10.1039\/D0SC00206B","article-title":"Self-assembly of reversed bilayer vesicles through pnictogen bonding: water-stable supramolecular nanocontainers for organic solvents","volume":"11","author":"Moaven","year":"2020","journal-title":"Chem. Sci."},{"key":"10.1016\/j.ccr.2025.216764_bb1265","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s10751-005-9172-6","article-title":"Study on stereochemical activity of lone pair electrons in sulfur and halogen coordinated antimony(III) complexes by 121Sb M\u00f6ssbauer spectroscopy","volume":"161","author":"Ohyama","year":"2005","journal-title":"Hyperfine Interact."},{"key":"10.1016\/j.ccr.2025.216764_bb1270","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1021\/j100785a001","article-title":"van der Waals Volumes and Radii","volume":"68","author":"Bondi","year":"1964","journal-title":"J. Phys. Chem."},{"key":"10.1016\/j.ccr.2025.216764_bb1275","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1021\/j100881a503","article-title":"van der Waals volumes and radii of metals in covalent compounds","volume":"70","author":"Bondi","year":"1966","journal-title":"J. Phys. Chem."},{"key":"10.1016\/j.ccr.2025.216764_bb1280","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1023\/A:1011625728803","article-title":"van der Waals Radii of Elements","volume":"37","author":"Batsanov","year":"2001","journal-title":"Inorg. Mater."},{"key":"10.1016\/j.ccr.2025.216764_bb1285","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.nucmedbio.2016.01.005","article-title":"Trithiols and their arsenic compounds for potential use in diagnostic and therapeutic radiopharmaceuticals","volume":"43","author":"DeGraffenreid","year":"2016","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.ccr.2025.216764_bb1290","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1039\/cc9960001975","article-title":"Hydrotris(methimazolyl)borate, a soft analogue of hydrotris(pyrazolyl)borate. Preparation and crystal structure of a novel zinc complex","author":"Garner","year":"1996","journal-title":"Chem. Commun."},{"key":"10.1016\/j.ccr.2025.216764_bb1295","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1002\/chem.200500677","article-title":"Lower main-group element complexes with a soft scorpionate ligand: the structural influence of stereochemically active lone pairs","volume":"12","author":"Dodds","year":"2006","journal-title":"Chem. Eur. J."},{"key":"10.1016\/j.ccr.2025.216764_bb1300","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s41181-024-00297-5","article-title":"Exploring a tristhione scorpionate ligand as a suitable chelator for the theranostic pair antimony-119 and antimony-117","volume":"9","author":"G\u00e9","year":"2024","journal-title":"EJNMMI Radiopharm. Chem."},{"key":"10.1016\/j.ccr.2025.216764_bb1305","doi-asserted-by":"crossref","first-page":"6665","DOI":"10.1039\/D5DT00261C","article-title":"Stereochemically (in)active lone pairs in Sb(III) complexes of a soft scorpionate ligand","volume":"54","author":"M\u00f8ller","year":"2025","journal-title":"Dalton Trans."},{"key":"10.1016\/j.ccr.2025.216764_bb1310","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.chemgeo.2011.11.004","article-title":"Stability and structure of pentavalent antimony complexes with aqueous organic ligands","volume":"292\u2013293","author":"Tella","year":"2012","journal-title":"Chem. Geol."},{"key":"10.1016\/j.ccr.2025.216764_bb1315","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1180\/minmag.2008.072.1.205","article-title":"Antimony(V) complexing with O-bearing organic ligands in aqueous solution: an X-ray absorption fine structure spectroscopy and potentiometric study","volume":"72","author":"Tella","year":"2008","journal-title":"Mineral. Mag."},{"key":"10.1016\/j.ccr.2025.216764_bb1320","doi-asserted-by":"crossref","first-page":"3733","DOI":"10.1039\/D0SC06867E","article-title":"Towards the stable chelation of radium for biomedical applications with an 18-membered macrocyclic ligand","volume":"12","author":"Abou","year":"2021","journal-title":"Chem. Sci."},{"key":"10.1016\/j.ccr.2025.216764_bb1325","doi-asserted-by":"crossref","first-page":"5772","DOI":"10.1039\/D2RA00642A","article-title":"Facile transmetallation of [SbIII(DOTA)]\u2212 renders it unsuitable for medical applications","volume":"12","author":"Chen","year":"2022","journal-title":"RSC Adv."},{"key":"10.1016\/j.ccr.2025.216764_bb1330","doi-asserted-by":"crossref","first-page":"7944","DOI":"10.1002\/chem.201402041","article-title":"Thermodynamic and kinetic study of scandium(III) complexes of DTPA and DOTA: a step toward scandium radiopharmaceuticals","volume":"20","author":"Pniok","year":"2014","journal-title":"Chem. Eur. J."},{"key":"10.1016\/j.ccr.2025.216764_bb1335","first-page":"905","article-title":"Aminoguanidinium (ethylenediamine-N,N,N\u2019,N\u2019-tetraacetato)antimonate(III) monohydrate","volume":"C55","author":"Fun","year":"1999","journal-title":"Acta Cryst."},{"key":"10.1016\/j.ccr.2025.216764_bb1340","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/461605","article-title":"Synthesis and crystal structure of the bioinorganic complex [Sb(Hedta)]\u00b72H2O","volume":"2014","author":"Li","year":"2014","journal-title":"Bioinorg. Chem. Appl."},{"key":"10.1016\/j.ccr.2025.216764_bb1345","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s11094-005-0097-9","article-title":"Cytotoxic and antitumor activity of antimony(III) nitrilotriacetate complexes M2SB(Nta)(HNta)\u00b7nH2O (M=NH4, Na; n=1, 2)","volume":"39","author":"Popov","year":"2005","journal-title":"Pharm. Chem. J."},{"key":"10.1016\/j.ccr.2025.216764_bb1350","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0020-1693(00)92617-3","article-title":"X-ray and white radiation neutron diffraction studies of optically active potassium antimony tartrate, K2Sb2(d-C4H2O6)2\u00b73H2O (tarter emetic)","volume":"8","author":"Gress","year":"1974","journal-title":"Inorg. Chim. Acta"},{"key":"10.1016\/j.ccr.2025.216764_bb1355","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1039\/c29710000018","article-title":"The crystal structure of the [Sb(C2O4)3]3\u2212 ion. A sterically active lone pair in six-co-ordination","author":"Poore","year":"1971","journal-title":"J. Chem. Soc. D"},{"key":"10.1016\/j.ccr.2025.216764_bb1360","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.nucmedbio.2022.04.005","article-title":"Radiolanthanum: promising theranostic radionuclides for PET, alpha, and Auger-Meitner therapy","volume":"110\u2013111","author":"Nelson","year":"2022","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.ccr.2025.216764_bb1365","doi-asserted-by":"crossref","DOI":"10.1088\/1361-6560\/aa9b44","article-title":"135La as an Auger-electron emitter for targeted internal radiotherapy","volume":"63","author":"Fonslet","year":"2017","journal-title":"Phys. Med. Biol."},{"key":"10.1016\/j.ccr.2025.216764_bb1370","doi-asserted-by":"crossref","first-page":"10658","DOI":"10.1038\/s41598-019-47137-0","article-title":"Production and in vivo PET\/CT imaging of the theranostic pair 132\/135La","volume":"9","author":"Aluicio-Sarduy","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ccr.2025.216764_bb1375","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1140\/epjp\/s13360-024-05917-2","article-title":"Proton-induced nuclear reactions on barium-136 for the production of the medically relevant radionuclide lanthanum-135","volume":"139","author":"Khomenko","year":"2024","journal-title":"Eur. Phys. J. Plus"},{"key":"10.1016\/j.ccr.2025.216764_bb1380","doi-asserted-by":"crossref","first-page":"584","DOI":"10.2967\/jnumed.121.262459","article-title":"First in vivo and phantom imaging of cyclotron-produced 133La as a theranostic radionuclide for 225Ac and 135La","volume":"63","author":"Nelson","year":"2022","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.ccr.2025.216764_bb1385","doi-asserted-by":"crossref","DOI":"10.1016\/j.apradiso.2022.110612","article-title":"Improved procedures for production and purification of 135La from enriched [135Ba]BaCO3 on a 16.5 MeV cyclotron","volume":"192","author":"Pedersen","year":"2023","journal-title":"Appl. Radiat. Isot."},{"key":"10.1016\/j.ccr.2025.216764_bb1390","doi-asserted-by":"crossref","DOI":"10.1016\/j.seppur.2021.119908","article-title":"Electrochemical separation of 132\/135La theranostic pair from proton irradiated Ba target","volume":"280","author":"Chakravarty","year":"2022","journal-title":"Sep. Purif. Technol."},{"key":"10.1016\/j.ccr.2025.216764_bb1395","series-title":"Lanthanide and Actinide Chemistry","first-page":"35","article-title":"Coordination chemistry of the lanthanides","author":"Cotton","year":"2006"},{"key":"10.1016\/j.ccr.2025.216764_bb1400","series-title":"Rare Earth Coordination Chemistry","first-page":"1","article-title":"Introduction","author":"Huang","year":"2010"},{"key":"10.1016\/j.ccr.2025.216764_bb1405","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1021\/ic50073a041","article-title":"Hydration thermodynamics of the lanthanide ions","volume":"8","author":"Bertha","year":"1969","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.ccr.2025.216764_bb1410","series-title":"Hydrolysis of Metal Ions","first-page":"225","article-title":"Scandium, yttrium and the lanthanide metals","author":"Brown","year":"2016"},{"key":"10.1016\/j.ccr.2025.216764_bb1415","series-title":"Rare Earth Coordination Chemistry","first-page":"91","article-title":"Rare earth complexes with carboxylic acids, polyaminopolycarboxylic acids, and amino acids","author":"Wang","year":"2010"},{"key":"10.1016\/j.ccr.2025.216764_bb1420","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0020-1693(94)03964-X","article-title":"Stability constants of the Lanthanide(III)-1,4,7,10-tetraazacyclododecane-N,N\u2032,N\u2032\u2032,N\u2032\u2032\u2032-tetraacetate complexes","volume":"221","author":"T\u00f3th","year":"1994","journal-title":"Inorg. Chim. Acta"},{"key":"10.1016\/j.ccr.2025.216764_bb1425","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1002\/chem.201905202","article-title":"Establishing radiolanthanum chemistry for targeted nuclear medicine applications","volume":"26","author":"Aluicio-Sarduy","year":"2020","journal-title":"Chem. Eur. J."},{"key":"10.1016\/j.ccr.2025.216764_bb1430","doi-asserted-by":"crossref","first-page":"22203","DOI":"10.1038\/s41598-020-79198-x","article-title":"High yield cyclotron production of a novel 133\/135La theranostic pair for nuclear medicine","volume":"10","author":"Nelson","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ccr.2025.216764_bb1435","doi-asserted-by":"crossref","first-page":"10429","DOI":"10.1021\/jacs.1c05339","article-title":"Py-Macrodipa: a Janus chelator capable of binding medicinally relevant rare-earth radiometals of disparate sizes","volume":"143","author":"Hu","year":"2021","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ccr.2025.216764_bb1440","doi-asserted-by":"crossref","first-page":"4125","DOI":"10.1021\/ic2001915","article-title":"Lanthanide DOTA-like complexes containing a picolinate pendant: structural entry for the design of LnIII-based luminescent probes","volume":"50","author":"Regueiro-Figueroa","year":"2011","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.ccr.2025.216764_bb1445","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.1021\/ja808534w","article-title":"Macrocyclic receptor exhibiting unprecedented selectivity for light lanthanides","volume":"131","author":"Roca-Sabio","year":"2009","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ccr.2025.216764_bb1450","doi-asserted-by":"crossref","first-page":"13500","DOI":"10.1021\/jacs.0c05217","article-title":"Macrocyclic ligands with an unprecedented size-selectivity pattern for the lanthanide ions","volume":"142","author":"Hu","year":"2020","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ccr.2025.216764_bb1455","doi-asserted-by":"crossref","first-page":"12847","DOI":"10.1021\/acs.inorgchem.2c01998","article-title":"Chelating rare-earth metals (Ln3+) and 225Ac3+ with the dual-size-selective macrocyclic ligand py2-macrodipa","volume":"61","author":"Hu","year":"2022","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.ccr.2025.216764_bb1460","doi-asserted-by":"crossref","first-page":"20699","DOI":"10.1021\/acs.inorgchem.3c01983","article-title":"Equilibrium thermodynamics of macropa complexes with selected metal isotopes of radiopharmaceutical interest","volume":"62","author":"Blei","year":"2023","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.ccr.2025.216764_bb1465","doi-asserted-by":"crossref","first-page":"9199","DOI":"10.1021\/acs.inorgchem.1c01269","article-title":"Tuning the kinetic inertness of Bi3+ complexes: the impact of donor atoms on diaza-18-crown-6 ligands as chelators for 213Bi targeted alpha therapy","volume":"60","author":"Fiszbein","year":"2021","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.ccr.2025.216764_bb1470","doi-asserted-by":"crossref","first-page":"14712","DOI":"10.1002\/anie.201709532","article-title":"An eighteen-membered macrocyclic ligand for actinium-225 targeted alpha therapy","volume":"56","author":"Thiele","year":"2017","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ccr.2025.216764_bb1475","doi-asserted-by":"crossref","first-page":"7933","DOI":"10.1021\/jm801055h","article-title":"Radiohalogenated prostate-specific membrane antigen (PSMA)-based ureas as imaging agents for prostate cancer","volume":"51","author":"Chen","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ccr.2025.216764_bb1480","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.2967\/jnumed.112.116624","article-title":"99mTc-labeled small-molecule inhibitors of prostate-specific membrane antigen for molecular imaging of prostate cancer","volume":"54","author":"Hillier","year":"2013","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.ccr.2025.216764_bb1485","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.3390\/ph15101167","article-title":"Efficient production of the PET radionuclide 133La for theranostic purposes in targeted alpha therapy using the 134Ba(p,2n)133La reaction","volume":"15","author":"Br\u00fchlmann","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ccr.2025.216764_bb1490","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.7150\/thno.92775","article-title":"Terbium radionuclides for theranostic applications in nuclear medicine: from atom to bedside","volume":"14","author":"Van Laere","year":"2024","journal-title":"Theranostics"},{"key":"10.1016\/j.ccr.2025.216764_bb1495","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ccr.2018.11.007","article-title":"Radiochemical processing of nuclear-reactor-produced radiolanthanides for medical applications","volume":"382","author":"Van de Voorde","year":"2019","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.ccr.2025.216764_bb1500","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1007\/s00259-013-2563-z","article-title":"Direct in vitro and in vivo comparison of 161Tb and 177Lu using a tumour-targeting folate conjugate","volume":"41","author":"M\u00fcller","year":"2014","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.ccr.2025.216764_bb1505","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1007\/s00259-019-04345-0","article-title":"Terbium-161 for PSMA-targeted radionuclide therapy of prostate cancer","volume":"46","author":"M\u00fcller","year":"2019","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.ccr.2025.216764_bb1510","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1007\/s00259-021-05564-0","article-title":"Combination of terbium-161 with somatostatin receptor antagonists\u2014a potential paradigm shift for the treatment of neuroendocrine neoplasms","volume":"49","author":"Borgna","year":"2022","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.ccr.2025.216764_bb1515","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.7150\/thno.15132","article-title":"Comparison between three promising \u03b2-emitting radionuclides, 67Cu, 47Sc and 161Tb, with emphasis on doses delivered to minimal residual disease","volume":"6","author":"Champion","year":"2016","journal-title":"Theranostics"},{"key":"10.1016\/j.ccr.2025.216764_bb1520","doi-asserted-by":"crossref","first-page":"759","DOI":"10.2967\/jnumed.115.170423","article-title":"Dose deposits from 90Y, 177Lu, 111In, and 161Tb in micrometastases of various sizes: implications for radiopharmaceutical therapy","volume":"57","author":"Hindi\u00e9","year":"2016","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.ccr.2025.216764_bb1525","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s40658-020-00301-2","article-title":"Radiation doses from 161Tb and 177Lu in single tumour cells and micrometastases","volume":"7","author":"Alcocer-\u00c1vila","year":"2020","journal-title":"EJNMMI Physics"},{"key":"10.1016\/j.ccr.2025.216764_bb1530","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.693682","article-title":"S.G. Wilkins and the CERN-MEDICIS collaboration, CERN-MEDICIS: A Review Since Commissioning in 2017","volume":"8","author":"Duchemin","year":"2021","journal-title":"Front. Med."},{"key":"10.1016\/j.ccr.2025.216764_bb1535","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.nimb.2013.11.013","article-title":"Cross sections of proton-induced reactions on 152Gd, 155Gd and 159Tb with emphasis on the production of selected Tb radionuclides","volume":"B 319","author":"Steyn","year":"2014","journal-title":"Nucl. Inst. Methods Phys. Res. A"},{"key":"10.1016\/j.ccr.2025.216764_bb1540","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.nucmedbio.2021.12.004","article-title":"New method for production of 155Tb via 155Dy by irradiation of natGd by medium energy alpha particles","volume":"106\u2013107","author":"Moiseeva","year":"2022","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.ccr.2025.216764_bb1545","doi-asserted-by":"crossref","first-page":"9827","DOI":"10.1021\/jacs.9b05337","article-title":"Molecular complex of Tb in the +4 oxidation state","volume":"141","author":"Palumbo","year":"2019","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ccr.2025.216764_bb1550","doi-asserted-by":"crossref","first-page":"13222","DOI":"10.1021\/jacs.9b06622","article-title":"Design, isolation, and spectroscopic analysis of a tetravalent terbium complex","volume":"141","author":"Rice","year":"2019","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ccr.2025.216764_bb1555","doi-asserted-by":"crossref","first-page":"9857","DOI":"10.1021\/ja403753j","article-title":"Completing the series of +2 ions for the lanthanide elements: synthesis of molecular complexes of Pr2+, Gd2+, Tb2+, and Lu2+","volume":"135","author":"MacDonald","year":"2013","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ccr.2025.216764_bb1560","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/0022-1902(62)80236-X","article-title":"Observations on the rare earths\u2014LXXV: the stabilities of diethylenetriaminepentaacetic acid chelates","volume":"24","author":"Moeller","year":"1962","journal-title":"J. Inorg. Nucl. Chem."},{"key":"10.1016\/j.ccr.2025.216764_bb1565","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1021\/ic00253a038","article-title":"Thermodynamic study of lanthanide complexes of 1,4,7-triazacyclononane-N,N\u2032,N\u2032\u2032-triacetic acid and 1,4,7,10-tetraazacyclododecane-N,N\u2032,N\u2032\u2032,N\u2032\u2032\u2032-tetraacetic acid","volume":"26","author":"Cacheris","year":"1987","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.ccr.2025.216764_bb1570","first-page":"3455","article-title":"Expression and localization of somatostatin receptor SSTR1, SSTR2, and SSTR3 messenger RNAs in primary human tumors using in situ hybridization","volume":"54","author":"Reubi","year":"1994","journal-title":"Cancer Res."},{"key":"10.1016\/j.ccr.2025.216764_bb1575","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1007\/BF01254561","article-title":"Evaluation in vitro and in rats of 161Tb-DTPA-octreotide, a somatostatin analogue with potential for intraoperative scanning and radiotherapy","volume":"22","author":"de Jong","year":"1995","journal-title":"Eur. J. Nucl. Med."},{"key":"10.1016\/j.ccr.2025.216764_bb1580","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/0024-3205(91)90052-D","article-title":"[111In-DTPA-D-Phe1]-octreotide, a potential radiopharmaceutical for imaging of somatostatin receptor-positive tumors: synthesis, radiolabeling and in vitro validation","volume":"49","author":"Bakker","year":"1991","journal-title":"Life Sci."},{"key":"10.1016\/j.ccr.2025.216764_bb1585","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.675122","article-title":"Radiolabeling of human serum albumin with terbium-161 using mild conditions and evaluation of in vivo stability","volume":"8","author":"Cassells","year":"2021","journal-title":"Front. Med."},{"key":"10.1016\/j.ccr.2025.216764_bb1590","doi-asserted-by":"crossref","first-page":"6997","DOI":"10.3390\/molecules26226997","article-title":"Hydroxypyridinones as a very promising platform for targeted diagnostic and therapeutic radiopharmaceuticals","volume":"26","author":"Zhou","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.ccr.2025.216764_bb1595","doi-asserted-by":"crossref","first-page":"20549","DOI":"10.1021\/acs.inorgchem.2c03671","article-title":"Comparative study of a decadentate acyclic chelate, HOPO-O10, and its octadentate analogue, HOPO-O8, for radiopharmaceutical applications","volume":"62","author":"Carbo-Bague","year":"2023","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.ccr.2025.216764_bb1600","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1021\/acs.bioconjchem.5b00572","article-title":"p-SCN-Bn-HOPO: a superior bifunctional chelator for 89Zr immunoPET","volume":"26","author":"Deri","year":"2015","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.ccr.2025.216764_bb1605","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.2967\/jnumed.112.107540","article-title":"A unique matched quadruplet of terbium radioisotopes for PET and SPECT and for \u03b1- and \u03b2\u2212-radionuclide therapy: an in vivo proof-of-concept study with a new receptor-targeted folate derivative","volume":"53","author":"M\u00fcller","year":"2012","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.ccr.2025.216764_bb1610","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1007\/s11172-023-4022-8","article-title":"Preparation of 155Tb-labeled short somatostatin analog","volume":"72","author":"Moiseeva","year":"2023","journal-title":"Russ. Chem. Bull."},{"key":"10.1016\/j.ccr.2025.216764_bb1615","doi-asserted-by":"crossref","first-page":"3458","DOI":"10.1021\/jm0200759","article-title":"Synthesis and biological evaluation of novel macrocyclic ligands with pendent donor groups as potential yttrium chelators for radioimmunotherapy with improved complex formation kinetics","volume":"45","author":"Chong","year":"2002","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ccr.2025.216764_bb1620","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1021\/bc100586y","article-title":"Efficient bifunctional decadentate ligand 3p-C-DEPA for targeted \u03b1-radioimmunotherapy applications","volume":"22","author":"Song","year":"2011","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.ccr.2025.216764_bb1625","doi-asserted-by":"crossref","first-page":"5971","DOI":"10.7150\/thno.75336","article-title":"3p-C-NETA: a versatile and effective chelator for development of Al18F-labeled and therapeutic radiopharmaceuticals","volume":"12","author":"Ahenkorah","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.ccr.2025.216764_bb1630","doi-asserted-by":"crossref","first-page":"19468","DOI":"10.1021\/acs.inorgchem.4c03571","article-title":"Radiochemistry and complex formation of the cyclen-derived chelator DOTI-Me with Mn2+, Cu2+, Zn2+, Ga3+, In3+, Tb3+, and Lu3+","volume":"63","author":"Hierlmeier","year":"2024","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.ccr.2025.216764_bb1635","doi-asserted-by":"crossref","first-page":"11435","DOI":"10.1002\/chem.202002999","article-title":"Synthesis and evaluation of a macrocyclic actinium-225 chelator, quality control and in vivo evaluation of 225Ac-crown-\u03b1MSH peptide","volume":"26","author":"Yang","year":"2020","journal-title":"Chem. Eur. J."},{"key":"10.1016\/j.ccr.2025.216764_bb1640","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.3390\/molecules28073155","article-title":"Preclinical evaluation of [155\/161Tb]Tb-crown-TATE\u2014A novel SPECT imaging theranostic agent targeting neuroendocrine tumours","volume":"28","author":"Wharton","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.ccr.2025.216764_bb1645","doi-asserted-by":"crossref","first-page":"13911","DOI":"10.1021\/acs.inorgchem.4c01180","article-title":"H3trica: versatile macrocyclic chelator for [225Ac]Ac3+ and [155\/161Tb]Tb3+ theranostics","volume":"63","author":"Fiaccabrino","year":"2024","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.ccr.2025.216764_bb1650","doi-asserted-by":"crossref","first-page":"4366","DOI":"10.1021\/ic00347a007","article-title":"Synthesis and crystal structure of a nine-coordinate gadolinium(III) complex of 1,7,13-triaza-4,10,16-trioxacyclooctadecane-N,N\u2019,N-triacetic acid","volume":"29","author":"Chen","year":"1990","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.ccr.2025.216764_bb1655","doi-asserted-by":"crossref","DOI":"10.1016\/j.apradiso.2020.109079","article-title":"165Er: a new candidate for Auger electron therapy and its possible cyclotron production from natural holmium targets","volume":"159","author":"Gracheva","year":"2020","journal-title":"Appl. Radiat. Isot."},{"key":"10.1016\/j.ccr.2025.216764_bb1660","first-page":"861","article-title":"Radionuclide therapy with iodine-125 and other Auger\u2013electron-emitting radionuclides: experimental models and clinical applications","volume":"18","author":"Bodei","year":"2003","journal-title":"Cancer Biother. Radiopharm."},{"key":"10.1016\/j.ccr.2025.216764_bb1665","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0883-2897(91)90044-L","article-title":"Potential for tumor therapy with iodine-125 labeled immunoglobulins","volume":"18","author":"Adelstein","year":"1991","journal-title":"Int. J. Rad. Appl. Instr. B"},{"key":"10.1016\/j.ccr.2025.216764_bb1670","series-title":"The Enzymes","first-page":"101","article-title":"Chapter seven - Auger electrons and DNA double-strand breaks studied by using iodine-containing chemicals","author":"Higashi","year":"2022"},{"key":"10.1016\/j.ccr.2025.216764_bb1675","series-title":"Biological Effects of the Auger Emitter Iodine-125: A Review. Report No. 1 of AAPM Nuclear Medicine Task Group No. 6, Med. Phys","first-page":"1361","volume":"19","author":"Sastry","year":"1992"},{"key":"10.1016\/j.ccr.2025.216764_bb1680","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3390\/instruments2030015","article-title":"First steps at the cyclotron of Orl\u00e9ans in the radiochemistry of radiometals: 52Mn and 165Er","volume":"2","author":"Vaudon","year":"2018","journal-title":"Instruments"},{"key":"10.1016\/j.ccr.2025.216764_bb1685","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.nimb.2007.01.287","article-title":"Study of activation cross-sections of deuteron induced reactions on erbium: production of radioisotopes for practical applications","volume":"B 259","author":"T\u00e1rk\u00e1nyi","year":"2007","journal-title":"Nucl. Inst. Methods Phys. Res. A"},{"key":"10.1016\/j.ccr.2025.216764_bb1690","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.1016\/j.nimb.2008.05.005","article-title":"Experimental Study of the 165Ho(p,n) nuclear reaction for production of the therapeutic radioisotope 165Er","volume":"B 266","author":"T\u00e1rk\u00e1nyi","year":"2008","journal-title":"Nucl. Inst. Methods Phys. Res. A"},{"key":"10.1016\/j.ccr.2025.216764_bb1695","doi-asserted-by":"crossref","first-page":"3529","DOI":"10.1016\/j.nimb.2008.05.123","article-title":"Experimental study of the 165Ho(d,2n) and 165Ho(d,p) nuclear reactions up to 20 MeV for production of the therapeutic radioisotopes 165Er and 166gHo","volume":"B 266","author":"T\u00e1rk\u00e1nyi","year":"2008","journal-title":"Nucl. Inst. Methods Phys. Res. A"},{"key":"10.1016\/j.ccr.2025.216764_bb1700","doi-asserted-by":"crossref","first-page":"4872","DOI":"10.1016\/j.nimb.2008.08.005","article-title":"Study of activation cross sections of proton induced reactions on erbium for practical applications","volume":"B 266","author":"T\u00e1rk\u00e1nyi","year":"2008","journal-title":"Nucl. Inst. Methods Phys. Res. A"},{"key":"10.1016\/j.ccr.2025.216764_bb1705","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.apradiso.2008.10.006","article-title":"Investigation of production of the therapeutic radioisotope 165Er by proton induced reactions on erbium in comparison with other production routes","volume":"67","author":"T\u00e1rk\u00e1nyi","year":"2009","journal-title":"Appl. Radiat. Isot."},{"key":"10.1016\/j.ccr.2025.216764_bb1710","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1007\/s10967-012-2116-0","article-title":"Evaluation of the cyclotron production of 165Er by different reactions","volume":"295","author":"Zandi","year":"2013","journal-title":"J. Radioanal. Nucl. Chem."},{"key":"10.1016\/j.ccr.2025.216764_bb1715","doi-asserted-by":"crossref","first-page":"7513","DOI":"10.3390\/molecules26247513","article-title":"A high separation factor for 165Er from Ho for targeted radionuclide therapy","volume":"26","author":"Da Silva","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.ccr.2025.216764_bb1720","doi-asserted-by":"crossref","first-page":"5330","DOI":"10.1021\/acs.inorgchem.3c03166","article-title":"High separation factor, high molar activity, and inexpensive purification method for the production of pure 165Er","volume":"63","author":"Saghez","year":"2024","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.ccr.2025.216764_bb1725","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1007\/s10967-021-07865-y","article-title":"Separation of 167Tm, 165Er and 169Yb from erbium targets irradiated by 60 MeV alpha particles","volume":"329","author":"Aliev","year":"2021","journal-title":"J. Radioanal. Nucl. Chem."},{"key":"10.1016\/j.ccr.2025.216764_bb1730","doi-asserted-by":"crossref","first-page":"4259","DOI":"10.1007\/s10967-022-08464-1","article-title":"New data on Ho(\u03b1,x) reactions and the aspects of 167Tm and 165Er production for medical use","volume":"331","author":"Kormazeva","year":"2022","journal-title":"J. Radioanal. Nucl. Chem."},{"key":"10.1016\/j.ccr.2025.216764_bb1735","doi-asserted-by":"crossref","DOI":"10.1016\/j.apradiso.2021.109919","article-title":"Experimental study of \u03b1-particle induced reactions on natural erbium for the production of Auger-emitters 167Tm, 165Er and 169Yb","volume":"177","author":"Kormazeva","year":"2021","journal-title":"Appl. Radiat. Isot."},{"key":"10.1016\/j.ccr.2025.216764_bb1740","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1049\/el:19870719","article-title":"Low-noise erbium-doped fibre amplifier operating at 1.54 \u03bcm","volume":"23","author":"Mears","year":"1987","journal-title":"Electron. Lett."},{"key":"10.1016\/j.ccr.2025.216764_bb1745","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1364\/OL.12.000888","article-title":"High-gain erbium-doped traveling-wave Fiber amplifier","volume":"12","author":"Desurvire","year":"1987","journal-title":"Opt. Lett."},{"key":"10.1016\/j.ccr.2025.216764_bb1750","series-title":"Erbium-Doped Fiber Amplifiers: Fundamentals and Technology","author":"Becker","year":"1999"},{"key":"10.1016\/j.ccr.2025.216764_bb1755","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1038\/s41563-021-01063-7","article-title":"A hybrid erbium(III)\u2013bacteriochlorin near-infrared probe for multiplexed biomedical imaging","volume":"20","author":"Wang","year":"2021","journal-title":"Nat. Mater."},{"key":"10.1016\/j.ccr.2025.216764_bb1760","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3390\/ph12030114","article-title":"Lutathera\u00ae: the first FDA- and EMA-approved radiopharmaceutical for peptide receptor radionuclide therapy","volume":"12","author":"Hennrich","year":"2019","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ccr.2025.216764_bb1765","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1097\/RLU.0000000000001240","article-title":"Radioligand therapy with 177Lu-PSMA-617 as a novel therapeutic option in patients with metastatic castration resistant prostate cancer","volume":"41","author":"Rahbar","year":"2016","journal-title":"Clin. Nucl. Med."},{"key":"10.1016\/j.ccr.2025.216764_bb1770","doi-asserted-by":"crossref","first-page":"13657","DOI":"10.1021\/acs.inorgchem.2c02183","article-title":"Chemical-shift standards for 199Hg NMR spectroscopy, 25 years later","volume":"61","author":"Zee","year":"2022","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.ccr.2025.216764_bb1775","doi-asserted-by":"crossref","first-page":"14241","DOI":"10.1021\/acs.inorgchem.4c02418","article-title":"Capturing mercury-197m\/g for Auger electron therapy and cancer theranostic with sulfur-containing cyclen-based macrocycles","volume":"63","author":"Tosato","year":"2024","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.ccr.2025.216764_bb1780","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1021\/jo00359a046","article-title":"A Mercury-199 NMR study of the complexation of methylmercury with thia-crown ethers. The absence of a macrocyclic ligand effect","volume":"51","author":"Bach","year":"1986","journal-title":"J. Organomet. Chem."},{"key":"10.1016\/j.ccr.2025.216764_bb1785","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1021\/ic011209w","article-title":"Sterically demanding multidentate ligand tris[(2-(6-methylpyridyl))methyl]amine slows exchange and enhances solution state ligand proton NMR coupling to 199Hg(II)","volume":"41","author":"Bebout","year":"2002","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.ccr.2025.216764_bb1790","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s40658-018-0216-9","article-title":"Molecular imaging using the theranostic agent 197(m)Hg: phantom measurements and Monte Carlo simulations","volume":"5","author":"Freudenberg","year":"2018","journal-title":"EJNMMI Physics"},{"key":"10.1016\/j.ccr.2025.216764_bb1795","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1172\/JCI103250","article-title":"Distribution of Radiomercury administered as labelled Chlormerodrin (Neohydrin\u00ae) in the kidneys of rats and dogs","volume":"35","author":"Greif","year":"1956","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ccr.2025.216764_bb1800","first-page":"89","article-title":"Brain scanning by means of 197Hg-labelled Neohydrin","volume":"72","author":"Matricali","year":"1969","journal-title":"Psychiatr. Neurol. Neurochir."},{"key":"10.1016\/j.ccr.2025.216764_bb1805","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.apradiso.2015.01.001","article-title":"Theranostic mercury: 197(m)Hg with high specific activity for imaging and therapy","volume":"97","author":"Walther","year":"2015","journal-title":"Appl. Radiat. Isot."},{"key":"10.1016\/j.ccr.2025.216764_bb1810","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1309\/5HY1-V3NE-2LFL-P9MT","article-title":"The toxicology of mercury","volume":"33","author":"Broussard","year":"2002","journal-title":"Lab. Med."},{"key":"10.1016\/j.ccr.2025.216764_bb1815","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.nimb.2020.05.014","article-title":"Revised cross-sections for formation of theranostic 197m,gHg in proton- and deuteron-induced reactions on 197Au","volume":"478","author":"Lebeda","year":"2020","journal-title":"Nucl. Inst. Methods Phys. Res. B"},{"key":"10.1016\/j.ccr.2025.216764_bb1820","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0168-9002(01)00174-7","article-title":"Proton-induced production of residual radionuclides in lead at intermediate energies","volume":"463","author":"Gloris","year":"2001","journal-title":"Nucl. Instrum. Methods Phys. Res., A"},{"key":"10.1016\/j.ccr.2025.216764_bb1825","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1007\/s10967-018-5927-9","article-title":"Production and isolation of 197m,gHg","volume":"317","author":"Despotopulos","year":"2018","journal-title":"J. Radioanal. Nucl. Chem."},{"key":"10.1016\/j.ccr.2025.216764_bb1830","doi-asserted-by":"crossref","DOI":"10.1063\/1.4983554","article-title":"Theranostic mercury part 1: a new Hg\/Au separation by a resin based method","volume":"1845","author":"Walther","year":"2017","journal-title":"AIP Conf. Proc."},{"key":"10.1016\/j.ccr.2025.216764_bb1835","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1080\/07366290701634594","article-title":"Characterization of extraction of chromatographic materials containing bis(2-ethyl-1-hexyl)phosphoric acid, 2-ethyl-1-hexyl (2-ethyl-1-hexyl)phosphonic acid, and bis(2,4,4-trimethyl-1-pentyl)phosphinic acid","volume":"25","author":"McAlister","year":"2007","journal-title":"Solvent Extr. Ion Exch."},{"key":"10.1016\/j.ccr.2025.216764_bb1840","doi-asserted-by":"crossref","first-page":"394","DOI":"10.2174\/1874471014999210111201630","article-title":"Meitner-Auger electron emitters for targeted radionuclide therapy: mercury-197m\/g and antimony-119","volume":"14","author":"Randhawa","year":"2021","journal-title":"Curr. Radiopharm."},{"key":"10.1016\/j.ccr.2025.216764_bb1845","series-title":"Encyclopedia of Inorganic Chemistry","article-title":"Mercury: Inorganic & Coordination Chemistry","author":"Bebout","year":"2005"},{"key":"10.1016\/j.ccr.2025.216764_bb1850","first-page":"799","article-title":"Mercury coordination compounds: classification and analysis of crystallographic and stuctural data","volume":"17","author":"Holloway","year":"1994","journal-title":"Main Group Met. Chem."},{"key":"10.1016\/j.ccr.2025.216764_bb1855","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1039\/dt9760002335","article-title":"Ring-size effects of macrocyclic ligands on complex stabilities. Mercury(II) complexes of twelve- to fifteen-membered cyclic tetra-amines","author":"Kodama","year":"1976","journal-title":"J. Chem. Soc. Dalton Trans."},{"key":"10.1016\/j.ccr.2025.216764_bb1860","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1039\/dt9780001081","article-title":"Equilibria of complex formation between several bivalent metal ions and macrocyclic tri- and penta-amines","author":"Kodama","year":"1978","journal-title":"J. Chem. Soc. Dalton Trans."},{"key":"10.1016\/j.ccr.2025.216764_bb1865","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1039\/c39790000140","article-title":"Encircling of mercury(II) by a macrocyclic ligand: X-ray crystal structure of 1,5,9,13-tetrathiacyclohexadecanemercury(II) perchlorate","author":"Jones","year":"1979","journal-title":"J. Chem. Soc. Chem. Commun."},{"key":"10.1016\/j.ccr.2025.216764_bb1870","doi-asserted-by":"crossref","DOI":"10.1002\/chem.202203815","article-title":"Selective chelation of the exotic Meitner-Auger emitter mercury-197m\/g with sulfur-rich macrocyclic ligands: towards the future of theranostic radiopharmaceuticals","volume":"29","author":"Randhawa","year":"2023","journal-title":"Chem. Eur. J."},{"key":"10.1016\/j.ccr.2025.216764_bb1875","doi-asserted-by":"crossref","first-page":"18983","DOI":"10.1039\/D4DT02427C","article-title":"Development of thiacrown ligands for encapsulation of mercury-197m\/g into radiopharmaceuticals","volume":"53","author":"Randhawa","year":"2024","journal-title":"Dalton Trans."},{"key":"10.1016\/j.ccr.2025.216764_bb1880","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1067\/mem.2003.72","article-title":"British anti-lewisite (Dimercaprol): an amazing history","volume":"41","author":"Vilensky","year":"2003","journal-title":"Ann. Emerg. Med."},{"key":"10.1016\/j.ccr.2025.216764_bb1885","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1172\/JCI101738","article-title":"Clinical uses of 2,3-dimercaptopropanol (BAL). XI. The treatment of acute mercury poisoning by BAL","volume":"25","author":"Longcope","year":"1946","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ccr.2025.216764_bb1890","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/0022-1902(77)80586-1","article-title":"Stability constants of the Hg2+-BAL complexes","volume":"39","author":"Coates","year":"1997","journal-title":"J. Inorg. Nucl. Chem."},{"key":"10.1016\/j.ccr.2025.216764_bb1895","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/2008-2231-22-46","article-title":"Current approaches of the management of mercury poisoning: need of the hour","volume":"22","author":"Rafati-Rahimzadeh","year":"2014","journal-title":"DARU J. Pharm. Sci."},{"key":"10.1016\/j.ccr.2025.216764_bb1900","doi-asserted-by":"crossref","first-page":"505","DOI":"10.3109\/15563659209017938","article-title":"Human studies with the chelating agents, DMPS and DMSA","volume":"30","author":"Vasken Aposhian","year":"1992","journal-title":"J. Toxicol. Clin. Toxicol."},{"key":"10.1016\/j.ccr.2025.216764_bb1905","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1021\/tx950096o","article-title":"Comparison of rac- and meso-2,3-dimercaptosuccinic acids for chelation of mercury and cadmium using chemical speciation models","volume":"9","author":"Fang","year":"1996","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.ccr.2025.216764_bb1910","series-title":"Bioinorganic Chemistry","first-page":"1","article-title":"Crown Thioether Chemistry","author":"Cooper","year":"1990"},{"key":"10.1016\/j.ccr.2025.216764_bb1915","series-title":"Recent Developments in Mercury Science","first-page":"107","article-title":"Mercury(II) complexes with thiacrowns and related macrocyclic ligands","author":"Grant","year":"2006"},{"key":"10.1016\/j.ccr.2025.216764_bb1920","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1016\/S0277-5387(00)80501-X","article-title":"Mercury thioether chemistry: the synthesis and structure of [Hg([9]aneS3)2](PF6)2 ([9]aneS3=1,4,7-trithiacyclononane)","volume":"8","author":"Blake","year":"1989","journal-title":"Polyhedron"},{"key":"10.1016\/j.ccr.2025.216764_bb1925","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0020-1693(02)01016-2","article-title":"Homoleptic group 12 metal complexes of macrocyclic thioethers: the crystal structures of bis(1,4,7-trithiacyclodecane)M(II) perchlorate: M(II)=zinc(II), cadmium(II), mercury(II)","volume":"338","author":"Helm","year":"2002","journal-title":"Inorg. Chim. Acta"},{"key":"10.1016\/j.ccr.2025.216764_bb1930","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/hc.1990.1.4.317","article-title":"1,4,7-Trithiacyclononane as a tridentate ligand for complexation of heavy-metal ions: synthesis and complexation studies of mesocyclic and macrocyclic polythioethers IV","volume":"1","author":"Setzer","year":"1990","journal-title":"Heteroat. Chem."},{"key":"10.1016\/j.ccr.2025.216764_bb1935","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1515\/znb-1993-0720","article-title":"Metallkomplexe mit 1,4,7-trithiacyclononan: kristallstrukturen von [CdI2\u00b7C6H12S3]2 und [Hg(C6H12S3)2](HgI3)2","volume":"B48","author":"Pickardt","year":"1993","journal-title":"Z. Naturforsch."},{"key":"10.1016\/j.ccr.2025.216764_bb1940","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1023\/A:1024954028516","article-title":"Mercury complexes with thiacrowns: the crystal structure of bis(1,4,7-trithiacyclodecane) mercury(II) hexafluorophosphate","volume":"33","author":"Helm","year":"2003","journal-title":"J. Chem. Crystallogr."},{"key":"10.1016\/j.ccr.2025.216764_bb1945","doi-asserted-by":"crossref","first-page":"5696","DOI":"10.1021\/ic050500z","article-title":"Mercury-199 NMR studies of thiacrown and related macrocyclic complexes: the crystal structures of [Hg(18S6)](PF6)2 and [Hg(9N3)2](ClO4)2","volume":"44","author":"Helm","year":"2005","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.ccr.2025.216764_bb1950","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1039\/DT9780000394","article-title":"Comparison of the different modes of bonding of the macrocycle in \u03bc-(1,4,8,11-tetrathiacyclotetradecane-S1S4;S8S11)-bis[dichloromercury-(II)] and aqua(1,4,8,11-tetrathiacyclotetradecane)mercury(II) perchlorate by X-ray structural analysis","author":"Alcock","year":"1978","journal-title":"J. Chem. Soc. Dalton Trans."},{"key":"10.1016\/j.ccr.2025.216764_bb1955","first-page":"565","article-title":"Structure of diiodo(1,4,8,11-tetrathiacyclotetradecane)mercury(II)","volume":"C42","author":"Gale\u0161i\u0107","year":"1986","journal-title":"Acta Cryst"},{"key":"10.1016\/j.ccr.2025.216764_bb1960","doi-asserted-by":"crossref","first-page":"1292566","DOI":"10.3389\/fchem.2024.1292566","article-title":"Exploration of commercial cyclen-based chelators for mercury-197m\/g incorporation into theranostic radiopharmaceuticals","volume":"12","author":"Randhawa","year":"2024","journal-title":"Front. Chem."},{"key":"10.1016\/j.ccr.2025.216764_bb1965","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1021\/ic030277a","volume":"43","author":"Hancock","year":"2004","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.ccr.2025.216764_bb1970","doi-asserted-by":"crossref","first-page":"2931","DOI":"10.1016\/S0277-5387(00)84203-5","article-title":"Mercury macrocyclic complexes: the synthesis of [Hg([18]aneN2S4)]2+ and [Hg(Me2[18]aneN2S4)]2+. The single crystal X-ray structure of [Hg([18]aneN2S4)](PF6)2\u00b74\/3H2O","volume":"9","author":"Blake","year":"1990","journal-title":"Polyhedron"},{"key":"10.1016\/j.ccr.2025.216764_bb1975","doi-asserted-by":"crossref","first-page":"10304","DOI":"10.1021\/ic901613s","article-title":"Mercury(II) recognition and fluorescence imaging in vitro through a 3D-complexation structure","volume":"48","author":"Ho","year":"2009","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.ccr.2025.216764_bb1980","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/00006231-199204000-00085","article-title":"83. Thiamacrocyclic bifunctional chelators for labelling antibodies with chemically \u2019soft\u2019 radiometals","volume":"13","author":"Blower","year":"1992","journal-title":"Nucl. Med. Commun."},{"key":"10.1016\/j.ccr.2025.216764_bb1985","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1080\/028418699431654","article-title":"Gamma camera imaging of platinum in tumours and tissues of patients after administration of 191Pt-cisplatin","volume":"38","author":"Areberg","year":"1999","journal-title":"Acta Oncol."},{"key":"10.1016\/j.ccr.2025.216764_bb1990","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S0360-3016(00)01419-X","article-title":"Antitumor effect of radioactive cisplatin (191Pt) on nude mice","volume":"49","author":"Areberg","year":"2001","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.ccr.2025.216764_bb1995","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/S0360-3016(99)00543-X","article-title":"In vitro toxicity of 191Pt-labeled cisplatin to a human cervical carcinoma cell line (ME-180)","volume":"46","author":"Areberg","year":"2000","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.ccr.2025.216764_bb2000","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0020-708X(85)90064-X","article-title":"Microscale syntheses of anti-tumour platinum compounds labelled with 191Pt","volume":"36","author":"Baer","year":"1985","journal-title":"Int. J. Appl. Radiat. Isot."},{"key":"10.1016\/j.ccr.2025.216764_bb2005","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0960-0760(92)90141-5","article-title":"Estrogen platinum-diamine complexes: preparation of a non-steroidal estrogen platinum-diamine complex labeled with platinum-191 and a study of its binding to the estrogen receptor in vitro and its tissue distribution in vivo","volume":"42","author":"DiZio","year":"1992","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.ccr.2025.216764_bb2010","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0969-8043(96)00267-9","article-title":"The synthesis of 191Pt labelled JM216, an orally active platinum anti-tumour agent","volume":"48","author":"Bates","year":"1997","journal-title":"Appl. Radiat. Isot."},{"key":"10.1016\/j.ccr.2025.216764_bb2015","doi-asserted-by":"crossref","first-page":"5690","DOI":"10.1021\/acs.jmedchem.1c02209","article-title":"Development of novel 191Pt-labeled Hoechst33258: 191Pt is more suitable than 111In for targeting DNA","volume":"65","author":"Obata","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ccr.2025.216764_bb2020","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.3390\/ph16111526","article-title":"Novel Auger-electron-emitting 191Pt-labeled pyrrole\u2013imidazole polyamide targeting MYCN increases cytotoxicity and cytosolic dsDNA granules in MYCN-amplified neuroblastoma","volume":"16","author":"Obata","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ccr.2025.216764_bb2025","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1128\/jb.94.6.1915-1918.1967","article-title":"Tracer studies to locate the site of platinum ions within filamentous and inhibited cells of Escherichia Coli","volume":"94","author":"Renshaw","year":"1967","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.ccr.2025.216764_bb2030","first-page":"349","article-title":"Distribution and retention of the antitumor agent 195mPt-cis-dichlorodiammine platinum (II) in man","volume":"15","author":"Smith","year":"1974","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.ccr.2025.216764_bb2035","doi-asserted-by":"crossref","first-page":"8140","DOI":"10.1038\/s41598-021-87576-2","article-title":"Synthesis of no-carrier-added [188,189,191Pt]cisplatin from a cyclotron produced 188,189,191PtCl42\u2212 complex","volume":"11","author":"Obata","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ccr.2025.216764_bb2040","first-page":"191","article-title":"The antitumor agent cis-Pt(NH3)2Cl2: distribution studies and dose calculations for 193mPt and 195mPt","volume":"14","author":"Lange","year":"1973","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.ccr.2025.216764_bb2045","doi-asserted-by":"crossref","first-page":"7010","DOI":"10.1073\/pnas.78.11.7010","article-title":"Base-pair substitution hotspots in GAG and GCG nucleotide sequences in Escherichia Coli K-12 induced by cis-diamminedichloroplatinum (II)","volume":"78","author":"Brouwer","year":"1981","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ccr.2025.216764_bb2050","doi-asserted-by":"crossref","first-page":"3436","DOI":"10.1021\/acs.chemrev.5b00597","article-title":"The next generation of platinum drugs: targeted Pt(II) agents, nanoparticle delivery, and Pt(IV) prodrugs","volume":"116","author":"Johnstone","year":"2016","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ccr.2025.216764_bb2055","series-title":"Cisplatin: Chemistry and Biochemistry of a Leading Anticancer Drug, Verlag Helvetica Chimica Acta","first-page":"3","article-title":"Platinum complexes for the treatment of cancer: why the search goes on","author":"Rosenberg","year":"1999"},{"key":"10.1016\/j.ccr.2025.216764_bb2060","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.nimb.2023.05.008","article-title":"Production of innovative radionuclides for medical applications at the CERN-MEDICIS facility","volume":"542","author":"Bernerd","year":"2023","journal-title":"Nucl. Inst. Methods Phys. Res. B"},{"key":"10.1016\/j.ccr.2025.216764_bb2065","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.apradiso.2007.10.009","article-title":"Production of the therapeutic radionuclides 193mPt and 195mPt with high specific activity via \u03b1-particle-induced reactions on 192Os","volume":"66","author":"Hilgers","year":"2008","journal-title":"Appl. Radiat. Isot."},{"key":"10.1016\/j.ccr.2025.216764_bb2070","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1524\/ract.2011.1807","article-title":"Small scale production of high purity 193mPt by the 192Os(\u03b1,3n)-process","volume":"99","author":"Uddin","year":"2011","journal-title":"Radiochim. Acta"},{"key":"10.1016\/j.ccr.2025.216764_bb2075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jlac.18440510102","article-title":"\u00dcber die Einwirkung des Ammoniaks auf Platinchlor\u00fcr","volume":"51","author":"Peyrone","year":"1844","journal-title":"Justus Liebigs Ann. Chem."},{"key":"10.1016\/j.ccr.2025.216764_bb2080","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/205698a0","article-title":"Inhibition of cell division in Escherichia Coli by electrolysis products from a platinum electrode","volume":"205","author":"Rosenberg","year":"1965","journal-title":"Nature"},{"key":"10.1016\/j.ccr.2025.216764_bb2085","series-title":"Advances in Antimicrobial and Antineoplastic Chemotherapy","first-page":"255","article-title":"Clinical experience with cisplatinous diammine dichloride","author":"Hill","year":"1971"},{"key":"10.1016\/j.ccr.2025.216764_bb2090","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.2967\/jnumed.117.206672","article-title":"In vivo characterization of platinum(II)-based linker technology for the development of antibody\u2013drug conjugates: taking advantage of dual dabeling with 195mPt and 89Zr","volume":"59","author":"Muns","year":"2018","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.ccr.2025.216764_bb2095","doi-asserted-by":"crossref","first-page":"4622","DOI":"10.3390\/ijms22094622","article-title":"In vitro evaluation of no-carrier-added radiolabeled cisplatin ([189,191Pt]cisplatin) emitting Auger electrons","volume":"22","author":"Obata","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ccr.2025.216764_bb2100","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1158\/0008-5472.CAN-18-1198","article-title":"Direct targeting of MYCN gene amplification by site-specific DNA alkylation in neuroblastoma","volume":"79","author":"Yoda","year":"2019","journal-title":"Cancer Res."},{"key":"10.1016\/j.ccr.2025.216764_bb2105","doi-asserted-by":"crossref","first-page":"5288","DOI":"10.1021\/ic00051a022","article-title":"Equilibria and dynamics of Tl(edta)X2\u2212 complexes (X=halide, pseudohalide) studied by multinuclear NMR","volume":"31","author":"Blixt","year":"1992","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.ccr.2025.216764_bb2110","series-title":"Advances in Inorganic Chemistry","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0898-8838(08)60115-4","article-title":"Advances in thallium aqueous solution chemistry","author":"Glaser","year":"1995"},{"key":"10.1016\/j.ccr.2025.216764_bb2115","series-title":"Principles and Practice of Nuclear Medicine","author":"Early","year":"1995"},{"key":"10.1016\/j.ccr.2025.216764_bb2120","first-page":"66","article-title":"Myocardial imaging with thallium-201 at rest and during exercise","volume":"56","author":"Ritchie","year":"1977","journal-title":"comparison with coronary arteriography and resting and stress electrocardiography, Circulation"},{"key":"10.1016\/j.ccr.2025.216764_bb2125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2967\/jnmt.109.068593","article-title":"Myocardial perfusion imaging with 201Tl","volume":"38","author":"Pagnanelli","year":"2010","journal-title":"J. Nucl. Med. Technol."},{"key":"10.1016\/j.ccr.2025.216764_bb2130","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1103\/PhysRev.178.1732","article-title":"Study of (p,xn) reactions at 400 MeV","volume":"178","author":"Church","year":"1969","journal-title":"Phys. Rev."},{"key":"10.1016\/j.ccr.2025.216764_bb2135","first-page":"151","article-title":"Thallium-201 for medical use","volume":"16","author":"Lebowitz","year":"1975","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.ccr.2025.216764_bb2140","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1524\/ract.2000.88.3-4.185","article-title":"Recovery of 201Tl by ion exchange chromatography from proton bombarded thallium cyclotron targets","volume":"88","author":"van der Walt","year":"2000","journal-title":"Radiochim. Acta"},{"key":"10.1016\/j.ccr.2025.216764_bb2145","first-page":"51","article-title":"Dependence of quality of thallium-201 on irradiation data","volume":"1","author":"Sattari","year":"2003","journal-title":"Int. J. Radiat. Res."},{"key":"10.1016\/j.ccr.2025.216764_bb2150","series-title":"Standard Potentials in Aqueous Solution","first-page":"237","article-title":"Gallium, indium, and thallium","author":"Losev","year":"1985"},{"key":"10.1016\/j.ccr.2025.216764_bb2155","series-title":"Encyclopedia of Inorganic Chemistry","article-title":"Thallium: inorganic chemistry","author":"T\u00f3th","year":"2005"},{"key":"10.1016\/j.ccr.2025.216764_bb2160","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1246\/bcsj.58.525","article-title":"Molecular design of crown ethers. 3. extraction of alkaline earth and heavy metal picrates with 14- to 17-crown-5 and 17- to 22-crown-6","volume":"58","author":"Inoue","year":"1985","journal-title":"Bull. Chem. Soc. Jpn."},{"key":"10.1016\/j.ccr.2025.216764_bb2165","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1021\/acs.bioconjchem.2c00284","article-title":"Toward bifunctional chelators for thallium-201 for use in nuclear medicine","volume":"33","author":"Rigby","year":"2022","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.ccr.2025.216764_bb2170","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.nucmedbio.2010.10.009","article-title":"Synthesis and in vivo evaluation of 201Tl(III)\u2013DOTA complexes for applications in SPECT imaging","volume":"38","author":"Hijnen","year":"2011","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.ccr.2025.216764_bb2175","doi-asserted-by":"crossref","first-page":"8670","DOI":"10.1021\/ja3024725","article-title":"H4Octapa: an acyclic chelator for 111In radiopharmaceuticals","volume":"134","author":"Price","year":"2012","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ccr.2025.216764_bb2180","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1021\/acs.bioconjchem.7b00311","article-title":"Orvig, p-NO2\u2013Bn\u2013H4neunpa and H4neunpa\u2013Trastuzumab: bifunctional chelator for radiometalpharmaceuticals and 111In immuno-single photon emission computed tomography imaging","volume":"28","author":"Spreckelmeyer","year":"2017","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.ccr.2025.216764_bb2185","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1021\/acs.bioconjchem.9b00225","article-title":"Functionally versatile and highly stable chelator for 111In and 177Lu: proof-of-principle prostate-specific membrane antigen targeting","volume":"30","author":"Li","year":"2019","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.ccr.2025.216764_bb2190","doi-asserted-by":"crossref","first-page":"5116","DOI":"10.1021\/acs.inorgchem.0c00372","article-title":"Oxyaapa: a picolinate-based ligand with five oxygen donors that strongly chelates lanthanides","volume":"59","author":"Hu","year":"2020","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.ccr.2025.216764_bb2195","doi-asserted-by":"crossref","first-page":"5426","DOI":"10.1021\/acs.inorgchem.5b00458","article-title":"[TlIII(dota)]\u2212: an extraordinarily robust macrocyclic complex","volume":"54","author":"Fodor","year":"2015","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.ccr.2025.216764_bb2200","doi-asserted-by":"crossref","first-page":"4291","DOI":"10.1021\/ic00047a016","article-title":"NMR study of solution structures and dynamics of lanthanide(III) complexes of DOTA","volume":"31","author":"Aime","year":"1992","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.ccr.2025.216764_bb2205","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1021\/ic0261272","article-title":"Equilibrium, 1H and 13C NMR spectroscopy, and X-ray diffraction studies on the complexes Bi(DOTA)\u2212 and Bi(DO3A-Bu)","volume":"42","author":"Csajb\u00f3k","year":"2003","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.ccr.2025.216764_bb2210","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/0020-1693(96)05130-4","article-title":"Crystal structure and solution dynamics of the lutetium(III) chelate of DOTA","volume":"246","author":"Aime","year":"1996","journal-title":"Inorg. Chim. Acta"},{"key":"10.1016\/j.ccr.2025.216764_bb2215","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1002\/ejic.201101164","article-title":"The solution structure and dynamics of MRI probes based on lanthanide(III) DOTA as investigated by DFT and NMR spectroscopy","volume":"2012","author":"Platas-Iglesias","year":"2012","journal-title":"Eur. J. Inorg. Chem."},{"key":"10.1016\/j.ccr.2025.216764_bb2220","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1021\/acs.molpharmaceut.4c00873","article-title":"Synthesis and characterization of thallium-texaphyrin nanoparticles and their assessment as potential delivery systems for Auger electron-emitting 201Tl to cancer cells","volume":"22","author":"Wulfmeier","year":"2024","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ccr.2025.216764_bb2225","doi-asserted-by":"crossref","first-page":"7900","DOI":"10.1039\/c0cc03528a","article-title":"Bismuth\u2013 and lead\u2013texaphyrin complexes: towards potential \u03b1-core emitters for radiotherapy","volume":"46","author":"Preihs","year":"2010","journal-title":"Chem. Commun."},{"key":"10.1016\/j.ccr.2025.216764_bb2230","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1021\/ic00066a032","article-title":"Synthesis and structural characterization of lanthanide(III) texaphyrins","volume":"32","author":"Sessler","year":"1993","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.ccr.2025.216764_bb2235","doi-asserted-by":"crossref","first-page":"12184","DOI":"10.1021\/ic400226g","article-title":"Recent developments in texaphyrin chemistry and drug discovery","volume":"52","author":"Preihs","year":"2013","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.ccr.2025.216764_bb2240","doi-asserted-by":"crossref","first-page":"222","DOI":"10.2174\/187152011795255894","article-title":"Texaphyrins: tumor localizing redox active expanded porphyrins","volume":"11","author":"Arambula","year":"2011","journal-title":"Anti Cancer Agents Med. Chem."},{"key":"10.1016\/j.ccr.2025.216764_bb2245","doi-asserted-by":"crossref","first-page":"5586","DOI":"10.1021\/ja00224a062","article-title":"An \u201cexpanded porphyrin\u201d: the synthesis and structure of a new aromatic pentadentate ligand","volume":"110","author":"Sessler","year":"1988","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ccr.2025.216764_bb2250","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0010-8545(96)01208-8","article-title":"Cation binding by thallium(I) selective crown ethers","volume":"148","author":"Ouchi","year":"1996","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.ccr.2025.216764_bb2255","doi-asserted-by":"crossref","first-page":"9039","DOI":"10.1039\/D2DT01074G","article-title":"To chelate thallium(I) \u2013 synthesis and evaluation of kryptofix-based chelators for 201Tl","volume":"51","author":"Frei","year":"2022","journal-title":"Dalton Trans."}],"container-title":["Coordination Chemistry Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010854525003340?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010854525003340?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T14:17:57Z","timestamp":1756390677000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010854525003340"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":451,"alternative-id":["S0010854525003340"],"URL":"https:\/\/doi.org\/10.1016\/j.ccr.2025.216764","relation":{},"ISSN":["0010-8545"],"issn-type":[{"value":"0010-8545","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Coordination chemistry of emerging Meitner-Auger electron-emitting radiometals for targeted radionuclide therapy","name":"articletitle","label":"Article Title"},{"value":"Coordination Chemistry Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccr.2025.216764","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"216764"}}